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Nanomaterials, which are by definition in the 1 - 100 nanometer range, have numerous 
possible benefits to society, but currently there is a lack of data that characterizes these 
materials effects on human health and environment.  In general nanomaterials are of 
interest to the Air Force because of their applications in electronics, sensors, munitions 
and energetic/reactive systems.  Nanoparticles such as aluminum have been considered 
for enhancing propulsion in solid rocket fuel.   To date, only a few studies have looked at 
the toxicological effects of direct exposure to nanoparticles, none with aluminum. It is 
important to increase the understanding of the nanomaterial exposure health impact 
before these materials are throughout diverse levels of occupations or fully used in large 
capacities within industry and the military.  The purpose of this research is to observe and 
characterize the in vitro cellular effects of rat lung macrophages to exposure to aluminum 
oxide nanoparticles (Al2O3-NP) (30 and 40nm) compared to aluminum nanoparticles (Al-
NP) (50, 80, and 120nm). This study concentrates on cell viability, mitochondrial 
function, phagocytosis ability, and cytokine response.  Results indicate no to minimal 
toxicological effects on macrophages exposed as high as 500 µg/ml for 24 hours with 
Al2O3-NP.  However, there was a significant delayed toxicity that occurred at 96 and 144 
h post exposure.  Al-NP indicate sight to moderate toxicity after 24 h exposure at 100 and 
250 µg/ml. The phagocytic ability of these cells was significantly hindered by exposure 
to each size of the Al-NP at 25 µg/ml for 24 hours, but not by the Al2O3-NP.  A series of 
cytokine and nitric oxide assays performed show none of these aluminum nanoparticles 
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IN VITRO TOXICITY OF ALUMINUM NANOPARTICLES 




 1.1   Background 
Nanotechnology provides a fundamental understanding of phenomena at the 
nanoscale level in order to create structures and devices that have novel properties and 
functions.  Nanomaterials may benefit the military and society, but currently there is little 
characterization of the effect of these materials on the environmental or human health.  
Nanoparticles (NP) and materials are of interest to the Air Force because of their 
applications in electronics, sensors, munitions and energetic/reactive systems.  Metal 
nanoparticles, such as aluminum, have applications, but only a few studies, none with 
aluminum, have looked at the toxicological effects of direct exposure to metal 
nanoparticles.  Characterization of potential nanoparticle exposure health impacts is 
critical, before these particles are fully integrated into industry and the military.   
NASA is currently investigating Al nanoparticles to increase the specific impulse of 
composite propellants in solid rocket fuel (Palazewski, 2002).  (Miziolek, 2004) at the 
Army Research Lab , demonstrated certain Al nanoparticle composites have great 
promise in explosives research.  Further, in 2004 the U.S. Naval Air Warfare Center 
investigated aluminum nanocomposites as “green” bullet primers and currently the Navy 
is using a nanocomposite of alumina-titania as wear resistant coatings on propeller shafts 







1.2   Problem Identification 
 
Although there are numerous applications of nanoparticles, specifically Al 
nanoparticles, there is little information on their biocompatibility or toxicity.  Only a few 
studies have looked at the toxicological effects of direct exposure to metal nanoparticles, 
however no studies have been done on aluminum toxicity. 
 
1.3   Research Questions 
 The purpose of this investigation was to determine the effect of aluminum 
nanoparticles on Rat Alveolar Macrophages.  Specifically, the following questions were 
addressed: 
1.  What effects do aluminum nanoparticles have on the viability of in vitro rat lung 
macrophages?   
2.   What are other exposure effects (morphology, phagocytosis, immune response) of 
aluminum nanoparticles on in vitro rat lung macrophages? 
 
1.4   Research Focus 
       The focus of this basic research was limited to the in vitro exposure of rat alveolar 
macrophages to various types of Al nanoparticles.  The goal was to give insight into 
inhalation toxicity of these particles in order to explore future modeling and in vivo 





     In Vitro techniques were used in this research.  Alveolar macrophages (AM) were 
cultured in plastic flasks and exposed to various concentrations of Al2O3-NP and Al-NPs 
for different time periods.  The viability, phagocytic ability, inflammatory response, and 
morphological characteristics of the cells were all observed. 
        The viability of the AM after exposure to each type of Al nanoparticle at various 
concentrations was determined by measuring the mitochondrial function of the cell as an 
indicator of metabolic activity and thus viability.  The colorimetric assay evaluates 
mitochondrial dehydrogenase reduction of Tetrazolium salt, 3-(4,5-dimethylthiazol-2-y)-
2,5-diphenyl tetrazolium bromide (MTT) to a blue formazan product (Carmichael et al., 
1985).   
        AM phagocytosis, after exposure to each type of Al nanoparticle, was measured by 
uptake of 2 µm latex beads, and observed with an Olympus IX71 inverted fluorescent 
microscope with CytoViva as a light source. A phagocytosis index was determined and 
compared to cells not exposed.  This method was developed from Paine et al., 2004. 
      The inflammatory response of the cells, after exposure to each type of Al NP was 
observed by determining the amount of inflammatory cytokines and Nitric Oxide 
produced.  In Vitro assay kits from Biosource Inc. were used to determine cytokine levels 
and in vitro kits from Promega Inc. were used to determine Nitric Oxide production.  
     Morphological characteristics of the cells, after exposure to each type of Al-NP, 
were observed with three different imaging techniques--basic light microscopy with an 
Olympus CK2-001T microscope, light microscopy with an Olympus IX71 inverted 
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fluorescent microscope with Cyto Viva as a light source, and Scanning Electron 
Microscopy (SEM).   
 
1.6   Assumptions/Limitations 
(1) Charaterization properties of Al NPs were expected to change after dry 
powder particles were suspended in deionized water and media.   
(2) Cells dosed at the same Al concentration had an equal level of exposure 
throughout the experiment and the exposure method used was satisfactory. 
(3) Despite the lack of evidence as to the effects of aluminum NP on human 
health, aluminum NPs were treated as possibly toxic to respiratory cells. 
(4) NP concentrations were selected from preliminary MTT assay results and 
used in the functional assay experiments.  These concentrations were not 
based on particle deposition data. 
(5) In Vitro results only give insight to expected future in vivo results   
 
1.7   Implications 
 
        Nanoparticles are being integrated into the workplace with little effort to identify 
potential health and environmental effects.  Research like this will help evaluate 
acceptable exposure limitations and measurements and help define control requirements 
and future regulations.  Identification of possible health and environmental effects is 
necessary if nanotechnology is to become more common.  Early characterization of 
negative health and environmental effects of these nanoparticles can help avoid previous 




1.8 Overview of Document 
       This document contains five chapters.   
Chapter Two: Reviews selected literature on current and future uses of nanoparticles, 
including: health and safety aspects, and an overview of aluminum toxicity.  It also 
demonstrates that toxicity in alveolar macrophages can be characterized according to cell 
viability, phagocytosis ability, immune response, and morphology.     
Chapter Three: Provides a concise explanation of the methods used to obtain data.   
Chapter Four:  Presents an analysis of data. 
Chapter Five:  Draws final conclusions and suggests future research.   
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II. Literature Review 
2.1 Background 
 This literature review provides a concise discussion on the current and future uses 
of nanoparticles in society and the current health and safety aspects of these particles.  It 
also includes specific uses of aluminum nanoparticles and a broad overview of the 
current understanding of aluminum toxicity and its involvement in disease and 
environmental degradation.  This literature review also demonstrates that toxicity in 
alveolar macrophages can be characterized according to cell viability, phagocytosis 
ability, immune response, and morphology.      
 
2.2 Nanoparticles (NPs) 
  NPs range between 1-100nm in size and display useful electrical, thermal, 
mechanical and imaging properties; however, an accurate characterization of their risk to 
health and the environment is lacking.  As NP applications improve and expand, the risks 
these particles present should be compared to their potential benefits (Dreher, 
2004),(Colvin 2003).  The large potential of these particles is seen by the large amounts 
of funding that the United States and other countries have invested in research and 
development of nanotechnology.   
 
2.2.1 Current and Future Uses 
 There are numerous different applications that currently exist for nanotechnology, 
and it would be impossible to cover all of them.  In order to gain insight as into how this 
technology is growing, a few examples of current nanotechnology and future applications 
are presented in this section. 
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 In the medical field, NPs are used in drug and vaccine delivery, including 
intravenous, intramuscular, and subcutaneous injections, and including oral and ocular 
administration (Kreuter, 1991).  NPs allow delivery of drugs that are non-ionic and not 
water soluble.  By encapsulating a drug with an NP hybrid, such as magnesium 
aluminum, the solubility of a drug can be increased and also provide potential for site 
direction to target cells.  This encapsulation has proven to increase the solubility of some 
drugs and holds promise for many other types (Tyner et al., 2004).  Anti-tumor drugs, 
delivered by NPs, might improve therapeutic response and even allow for monitoring the 
amount of drug taken in by tumor cells (Kukowska-Latallo et al., 2005).  Not only are 
NPs being used to get the drugs to the right place, but they are also being looked at as 
drugs themselves.  Silver NPs have shown to have the ability to attach to the glycoprotein 
knobs on the HIV-1 virus and prevent the virus from entering cells and replicating 
(Elechiguerra et al., 2005).   
 Electronics and sensors are some of the most promising areas of research and 
development (R&D) for NPs.  These particles have properties that make them desired as 
conducting composites.  For example, carbon nanotubes can carry more current density 
than any metal, as high as 1000 times the current density of copper (Kuennen, 2004).  
Interactive touch screens can be produced with optically transparent conductive coatings 
of indium tin oxide and antimony tin oxide nanoparticles that are simply painted onto 
surfaces (Robertson, 2004).  These conductive properties provide the ability to produce 
devices at the nano scale and leading to improvements in sensor technology.   Currently 
there are 200 tiny sensors called Micro-Electronic-Mechanical Systems (MEMS) on the 
Golden Gate Bridge.  They are used to collect data on traffic, wind, and seismic activity.  
Future applications of these small sensors could be used on bridges and roads all over the 
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world.  The department of Defense has used the word “smart dust” to describe similar 
sensors that would be the size of a period.  These could be used as suggested above, or on 
the battle field as real time reconnaissance tools (Kuennen, 2004). 
 NPs are important in improving current materials.  Surfaces can be made resistant 
to abrasion with the addition of aluminum oxide and titanium oxide particle coatings 
(Dingman, 2005) and nanotechnology can lead to surfaces that are able to shed water 
(Kuennen, 2004).  Metal matrix composites are being explored for improved applications 
in defense, aerospace and automotive industries.  Composites such as carbon, boron and 
silicon carbide are used to reinforce aluminum and magnesium.  Improved properties of 
these metal composites have allowed them to have many new aerospace applications 
(Dingman, 2005) and (Robertson, 2004).  Work is being done to explore self healing 
polymers that might possibly lead to “self-healing roads” and numerous other possible 
applications on high wear areas (Kuennen, 2004).   
 Nanomaterials are also being explored as a sustainable way to capture energy 
from the sun.   Nanotechnology is now at a point where thin films of organic 
nanostructures can be made.  These thin layers of semiconducting organic materials  
capture photons from the sun and use them as energy.  These organic photovotaics have a 
lot of promise due to the fact they are cheap and easy to make (Dingman, 2005).   
Photovoltaic fibers have been developed and demonstrated as a new technology to be 
used by the military (Department of Defense Director, Defense Research and 
Engineering, 2005). 
    We may soon find ourselves in contact with silver, zinc and copper nanoparticles in 
our everyday lives, due to their anti-microbial characteristics.   A good example of this is 
zinc oxide nanopowders that are being explored for uses in deodorants, dental cleansers, 
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and diaper creams.  Copper oxide nanopowder is also a possible future product as an 
antimicrobial preservative for wood and food products. (Dingman, 2005). 
 The importance of nanotechnology is evident due to the global growth of RD in 
this area.  This is seen in the amount of money that governments are allocating to RD.  
Funding towards RD has increase seven fold from 1997 to 2003 and the United States has 
been a leader in the pack with $849 million dollars in 2004.  Table 2-1 breaks down the 
major contributors toward RD in nanotechnology over the last eight years.  Industry 
believes that worldwide production in nanotechnology could reach 1 trillion dollars in the 
next 8 to 12 years, and this would require about 2 million nanotechnology workers (Roco, 
2003).  President Bush signed the 21st century Nanotechnology Research and 
Development Act that allocates $3.4 billion dollars to the National Nanotechnology 
Initiative over the next four years from 2005 thru 2008, Table 2-2 (Kuennen, 2004).  
Figure 2-1 Illustrates the relationship between R&D investments and the number of 






































































Millions $ Invested Articles Published
 
 
Figure 2-1 Nanotechnology Investments and Articles Published in Science 
 
Blue line indicated the number of articles published in the Journal Science (determined 
by an on-line search using nanotechnology, nanomaterial, and nanoparticles as key words 
in the title and abstracts of the articles) (Science, 2006).  The bar graph numbers were 
taken from (Roco, 2003) 
 
 








Table 2-2 – Allocation of funds for the 21st century Nanotechnology Research and 
Development Act (Kuennen, 2004) 
 
 
2.2.2 Uses of Aluminum Nanoparticles 
Aluminum nanoparticles have been used in drug delivery, improvements in surface 
coatings, and in improvements of metal alloys. Production of nanopowders such as iron 
aluminide (FeAl) and iron aluminum carbide (Fe3AlC0.5) show promise in low density, 
high tensile strength, and corrosive resistant material production.  It has been suggested 
that reducing the size of FeAl to the nanoparticle range will increase the strength of these 
materials.  The uses of Fe3AlC0.5 with FeAl offer the same advantages as Ni3Al, but at a 
lower cost (Pithawalla, 2004).    
 Aluminum nanoparticles are potential ingredients for solid rocket fuels of the 
future.  Aluminum was first introduced to rocket fuel in the early 1960’s when Keith 
Rumbel and Charles Henderson found that adding aluminum increased the specific 
impulse of a composite propellant and that one of the many conditions for good 
combustion was a small particle size.  Key missiles and boosters that have used 
aluminum as fuel are the Polaris rockets A1-A3 established 1960-1964, the Minuteman I 
rockets Stage 1-3 in 1962, the Titan 3 solid-rocket motor in 1965, and the current space 
shuttle solid-rocket booster in 1981 (Hunley, 1999).  In a hypothetical mission to Mars, 
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Palazewski infers that adding micro sized aluminum particles to solid rocket fuel, at 60% 
by weight, could increase the thrust of the rocket enough to carry 22% more payload and 
as much as a 33% increase by adding 70% by weight (Palazewski, 2002).  Past usage of 
aluminum in solid rocket fuel has been in the micrometer size range, but future 
applications may involve NASA and DoD using nanoscale aluminum nanoparticles as a 
propellant ingredient (Romano, 2005).  The particles NASA is investigating range in size 
from 20 to 100 nm with a 2 to 3 nm thick oxidized coat (Aluminum oxide Al2O3).  This 
new size of particle will allow for increases in fuel density, safety, and exhaust velocity.  
It will also reduce fuel slosh, leakage, and the overall size of the vehicle (Palaszewski, 
2002).  Programs have been set in motion to explore the benefits of the metallized gelled 
rocket propellants by the U.S. Army Missile Command and the NASA Lewis Research 
Center (Palaszewski, 1997). 
 Another potential DoD use for these particles is in explosives and artillary. 
Miziolek, at the US Army Research Lab, looked at Metastable Intermolecular 
Composites (MICs).  These are mixtures of metallic nanopowders that have an 
exothermic behavior.  In an explosive reaction, the amount of energy being released can 
be dictated by the size of the nanoparticles in the weapon.  Three MICs are showing 
promises and all three contain aluminum nanoparticles: Al/MoO3, Al/Teflon, and Al/CuO 
(Miziolek, 2002). Aluminum nanoparticles are being explored by the U.S. Naval Air 
Warfare Center as a possible replacement for lead primers in artillary.  If all tests are 
successful, this new type of “green” bullet is likely to be used some time next decade 
(Loney, 2004).   
 Currently the Navy is using a thermal spray made of a ceramic nanocomposite 
alumina-titania.  This nanomaterial is used to produce wear resistant coatings on 
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propeller shafts of Mine Countermeasure Ships.  With support from Small Buisness 
Innovative Research this product has been commercialized and is being evaluated for 
possible use on the rest of the fleet and on through-hull ball valves on submarines 
(Department of Defense Director, Defense Research and Engineering, 2005).  
 
2.3 Health and Safety  
Exposure to nanoparticles will keep increasing due to improvements to the quality 
of consumer products, medicine, and other technological applications (Dreher, 2004).  
Assessment of health and environmental risks of nanoparticles, both in industry and 
society, are lacking. Due to their different characteristics these particles should be 
considered separate from their macro sized counterparts, in terms of toxicity.  As 
applications improve and expand, the question that needs to be answered is whether the 
risks these particles have on health and the environment is reasonable compared to their 
potential benefits to society.  (Dreher, 2004) and (Colvin, 2003). 
 
2.3.1 Surface Characteristics 
 One of the physical properties that make nanoparticles desirable could also 
increase their toxicity.  When the size of these particles decreases, the free surface area of 
the material at the same volume will increase dramatically.  These free surfaces interact 
with cells.  Gupta et al in 2004 found that coating superparamagnetic iron oxide 
nanoparticles, which are toxic to cells, with pullalan resulted in no toxicity and a different 
endocytosis behavior as compared to uncoated nanoparticles.   Yang et al in 2005 found 
that when aluminum nanoparticles are coated with phenanthrene that their pytotoxic 
effects on root elongation in corn, cucumber, soybean, cabbage, and carrots was reduced 
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compared to aluminum that was not coated.  Renwick concluded from his research that 
ultra fine carbon black, at a low volume, will impair macrophage phagocytosis due to its 
high surface area (Renwick et al, 2000).  These examples are relevant in understanding 
surface interactions these cells have with the nanoparticles and why the toxicity of these 
materials should be characterized within a range of different sizes and surface 
characteristics. 
 
2.3.2 Occupational Exposure 
Mulhausen and Domingo in 1998 present a strategy for assessing and managing 
occupational exposures.  As seen in Figure 2-1, goals are set first, then a basic 
characterization of the potential toxicants is identified in order to establish acceptable 
level of exposures.  Next, these levels are measured over time and more controls are 
added if exposure is too high, more information is gathered if exposure level is uncertain, 
or reassessed if exposure levels are acceptable.  This cyclic process feeds data back into 
the basic characterization step (Mulhausen and Domiano, 1998:6-12).   
The basic characterization for aluminum is available in numerous locations. 
Material Safety Data Sheets (MSDS) are good initial source of information, but they are 
limited and may not be adequate, due to lack of toxicology data (Mulhausen and 
Domiano, 1998:30). The health effects of excessive exposure to aluminum in general will 
be addressed in the next section, a list of significant occupational sources of exposure and 
blood/serum/urine levels is seen below in Table 2-3.  MSDSs, the table below, and others 
sources do not include nanoparticle exposure and health risk information. Overall the 
characterization of nanoparticles such as aluminum and aluminum oxide compared to 
their macro sized counterparts is lacking.    
                          
 
Figure 2-2 - A strategy for assessing and managing occupational exposure 
(Mulhausen and Domiano, 1998:7) 
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Table 2-3 - Blood/plasma/serum and urine concentrations of aluminum in 
workers occupationally exposed and in occupationally nonexposed 




The EPA and the National Science Foundation recognized the following risk 
assessment issues that still need to be addressed regarding the manufacturing of 
nanoparticles: exposure assessment, toxicology, extrapolation of toxicology using 
existing particle and fiber databases, recyclability of materials, and environmental fate, 
transport, persistence and transformation of nanoparticles (Dreher, 2004).  The Institute 
of Occupational Medicine prepared a report for the Health and Safety Executive in 2004.  
In this report they looked at nanoparticle occupational hygiene and, in summary, found 
 16 
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there is not enough evidence to say that the exposure of workers from the production of 
nanoparticles has been adequately assessed (Aitken et al., 2004).   
 
2.3.3 Regulations 
Concerns with production of nanoparticles include adverse effect on human and 
environmental health, bioavailability, and transport.  The EPA has primarily focused its 
authority to regulate nanotechnology under the Toxic Substance Control Act (TSCA).  
This act requires the listing of all chemicals in U.S. commerce, a review of new 
chemicals before they are introduced, testing the chemicals for their effect on human and 
environmental health, and establishing reporting, recordkeeping, import and export 
requirements for chemicals.  The Clean Air Act, Clean Water Act, Resource 
Conservation and Recovery Act, and the National Environmental Policy Act also have 
some influence and pull on nanotechnology (Hoffman, 2004).  These current regulations 
are in place to control production of new nanotechnologies, but their adequacy is still 
questioned. This debate will continue until the health and environmental effects of these 
nanoparticles are fully characterized.  
2.3.4 Future Concerns and Funding 
 The mass production and expanding scope of use of these nanoparticles in society 
has caused some concern.  Asbestos had a great number of uses and a great deal of 
promise in industry, but the characterization of asbestos in regard to human health was 
only fully understood recently.  In President Bush’s January 2005 press release, he 
estimates that future transactions in asbestos lawsuits will be between $145 and $210 
billion (White House Press release 2005).  DDT is another example of toxic chemical 
whose risk to the environment was never fully characterized before its use (Hoffman, 
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2004).  These two examples may be extreme, but they illustrate the value of 
characterizing these nanoparticle effects on human and environmental health before they 
are totally integrated into society. 
 In 2005 the US EPA, National Institute for Occupational Safety and Health 
(NIOSH), and the National Science Foundation (NSF) awarded $7 Million in grants for 
research on implications of nanotechnology and manufactured nanomaterials on human 
health and the environment (EPA, 2005).  This is a small fraction compared to $3.4 
billion by the 21st century Nanotechnology Research and Development Act seen in 
Tables 2-1 and 2-2. 
2.4 Aluminum Toxicity 
 Aluminum is the third most abundant element in the lithosphere, behind silicon 
and oxygen, but is almost non existent in humans and biological systems.  Exley explains 
that biochemical cycles of elements, from the lithosphere into organisms, can give insight 
into natural selection against these elements by organisms, and creates a strong case that 
aluminum has been excluded from biochemical processes via evolution (Exley, 2003).  If 
organisms have been excluding uptake of aluminum over evolutionary time there must be 
some good reasons.  The next two sections will address problems involving 
environmental contamination and known human diseases associated with aluminum in 
general.  
 
2.4.1 Environmental Contamination 
Aluminum toxicity has been discussed at length with regards to decreases in soil 
and water pH.  Figure 2-2 illustrates that the percent of total aluminum and Al+3 species 
will increase as pH decreases.  Once pH is below 5.5 toxic effects have been documented 
for plants, invertebrates, amphibian larva, and fish.  At a pH below 4.5 the dominant 
species is Al+3 and hinders cation exchange and electrolyte balances in organisms.   
               
Figure 2-3- Solubility of Aluminum Species (Percent solubility versus pH) 
(Yokel and Golub, 1996: Ch 1, 20) 
  
Decreases of pH between 6.5 and 5.5 have caused fish to experience asphyxiation.  
This is due to aluminum’s effects on the gills, causing high ventilation rates, low oxygen 
blood tension, and overall gill damage that include an increase in gill mucus production, 
and coughing rates (Yokel and Golub, 1996: Ch 3, 50-52).  High aluminum 
concentrations affect ion and calcium regulation and respiratory rates in invertebrates. 
One study found that mayflies will tend to avoid high concentrations of aluminum in 
water (Yokel and Golub, 1996: Ch 3, 49-50).  Since aluminum has found its way into the 
food chain by accumulating in plants and invertebrates, birds and mammals both are most 
likely to be exposed to aluminum via their diets.  In birds, aluminum affects egg 
production, bone structure and embryonic development.  In domesticated mammals it has 
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been found to cause a decrease in food intake, a decrease in weight gain by young 
animals, and an increase in weight loss by adults (Yokel and Golub, 1996: Ch 3, 52-56).     
Aluminum is also a phytotoxin and is considered to be a major limiting factor in 
crop production (Noble, et al 1988).  Again, toxicity is seen when aluminum is leached 
out of soil via a drop in pH.  This is significant since low pH soils make up 30% of land 
area on the world (Yokel and Golub, 1996: Ch 3, 52-56).  Plant effects caused by 
aluminum are well documented.  Noble identified a correlation between the decreased tap 
root length in soy bean plants and the amount of liable aluminum available to the plant 
(Noble, et al. 1988).  Pavan found that aluminum concentrations at 62 to 100 micrograms 
per gram of leaf in coffee plants causes a decrease in root and shoot growth.  He also 
found that coffee seedling lengths also correlated to aluminum available in the soil 
(Pavan et al., 1982).  Root elongation in barley seedlings is strongly correlated with Al+3 
species, but not with total aluminum (Cameron et al., 1986).  This again relates back to 
the pH levels causing Al+3 to become the dominant species.  
   
2.4.2 Exposure and Human Disease 
Inhalation exposure to aluminum has been linked to numerous physiological 
problems and a few specific diseases. The Toxicological Profile for Aluminum developed 
by the U.S. Department of Health and Human Services contains a concise history of 
research in aluminum occupational exposure.  It contains information on symptoms that 
are seen after exposure via inhalation, oral, and dermal contact.  For the purpose of this 
research, the inhalation exposure effects, along with other current literature, will be 
reviewed to evaluate the currently known links between aluminum exposure and disease. 
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2.4.2.1   Fibrosis 
Idiopathic Pulmonary Fibrosis as defined by the Merk Manual is the “Chronic 
inflammation of the alveolar walls with progressive fibrosis, of unknown etiology” 
(Beers and Berkow, 1999: 635).  Fibrosis is the most common reported respiratory effect 
observed by workers chronically exposed to aluminum dust, powders or fumes.  There 
are a few studies in which male factory workers that were chronically exposed to 
aluminum flake powder had died as a result of hypertrophy of the right side of the heart 
due to fibrosis.  Most cases of occupational exposure to aluminum involve simultaneous 
exposure to another particle.  In many cases, the other material, such as silica, is found to 
be the agent that causes the fibrosis.  A number of studies have looked at aluminum dust 
and fume exposure in potrooms and found workers exhibiting symptoms such as 
wheezing, dyspnea, and impaired lung function, but again since these workers are 
exposed to a number of other chemicals already considered toxic, respiratory effects of 
aluminum could not be characterized (Toxicological Profile for Aluminum (update), 
1999, 14,23). 
2.4.2.2    Hematological Effects 
Aluminum exposure has been seen to affect red blood cell numbers, oxygen uptake 
ability, and clotting ability.  Anemia as defined by the Merk Manual is the “Decrease in 
the numbers of RBCs or hemoglobin content caused by blood loss, deficient 
erythropoiesis, excessive hemolysis, or a combination of these changes” (Beers and 
Berkow, 1999: 849).  Aluminum causes decreased hemoglobin synthesis in bone marrow 
cells and erythroleukemia cells resulting in microcrytic hypochromic anemia.  Aluminum 
also appears to affect the amount of intracellular iron available to hemoglobin (Yokel and 
Golub, 1996: Ch 7, 137-140).  In the case of acute occupational exposure, no 
 22 
hematological effects are seen, but decreases in red blood cell hemoglobin and increased 
sedimentation rates have been reported on workers that are chronically exposed to 
aluminum flake powder.  In a study on 36 workers that were chronically exposed to 
aluminum dust, 30 of them had an increase in blood clotting times (Toxicological Profile 
for Aluminum (update), 1999: 25).   
 
2.4.2.3 Endocrine System Effects 
Aluminum exposure has been identified to have certain effects on endocrine 
organs or the hormones they produce.  Post mortem enlargement of the thyroid gland was 
found in a male factory worker that was chronically exposed to aluminum dust via 
inhalation (Toxicological Profile for Aluminum (update), 1999: 27).  Baydar recognized 
that there are many similarities between chromium (Cr), essential in glucose metabolism, 
and aluminum.  Urine and plasma samples were taken from diabetic patients and healthy 
volunteers to determine the Al/Cr ratio.  The ratio was high in diabetic patients compared 
to the healthy controls suggesting that there may be a mechanism where aluminum levels 
might induce diabetes (Baydar et al., 1997).  Another study was done on the production 
of testosterone after aluminum exposure.  With the use of rats, it was determined that 
inhalation of AlCl will increase nitric oxide synthesis and this will inhibited testosterone 
production (Guo et al., 2001).  Chih-Hung in 2003 also suggests that the nitric oxide 
produced is responsible for allowing aluminum to cross the blood-testis barrier and 
accumulate in the testis (Chih-Hung et al, 2004).  This may have significance in 
aluminum crossing the blood-brain barrier and causing neurological effects.  
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2.4.2.4   Neurological Effects 
Aluminum welders, chronically exposed to aluminum fumes, were evaluated on 
neurobehavioral performance, and found to have no alterations, but in those workers, 
there was a correlation between urinary levels of aluminum and memory test 
performance.  There was also a correlation between plasma aluminum levels and visual 
reaction time tests.  Other studies found that aluminum foundry workers and welders had 
alterations in eye hand coordination, memory, and sub clinical tremors (Toxicological 
Profile for Aluminum (update), 1999: 29-30). 
 Alzheimer’s Disease as defined by Merck is “ A progressive, inexorable loss of 
cognitive function associated with an excessive number of senile plaques in the cerebral 
cortex and subcortical gray matter, which also contains beta-amyloid and neurofibrillary 
tangles consisting of tau protein” (Beers and Berkow, 1999: 1395-1396).  In 1994, Shin 
determined that aluminum binds to these tau proteins and causes them to aggregate and to 
not go through proteolysis.   This results in aluminum modulating tau plaques and tangle 
formation as described in the definition of Alzheimer’s disease (Shin et al., 1994).  
Aluminum-induced tangles tend to happen in the neurons of the spinal cord, cerebellum, 
brain stem, and in long term studies, they were found in cortical areas and the 
hippocampus of the brain (Itzhaki, 1994).  In 1996, a control study was completed that 
indicated no relation between occupational exposure due to inhalation of aluminum dust 
or fumes to Alzheimer’s disease, resulting in more emphasis being placed on oral 
exposure of aluminum and Alzheimer’s disease (Toxicological Profile for Aluminum 




2.4.2.5 Musculoskeletal Effects 
A few occupational exposure studies have been done on aluminum exposure and 
musculoskeletal effects.  One study identified a female that exhibited joint pain after 
chronic inhalation exposure to alumnite residue, and another reported chronic inhalation 
exposure to aluminum powders by two male factory workers resulted in clubbed fingers 
(Toxicological Profile for Aluminum (update), 1999: 26).  Merck defines clubbed fingers 
as the “enlargement of the terminal digital phalanges with loss of nail bed angle”.  This 
condition is seen in a variety of cases including numerous pulmonary diseases (Beers and 
Berkow, 1999: 520).  Most musculoskeletal effects are seen on dialysis patients that are 
subjected to high intravenous aluminum concentrations.  High aluminum levels retard 
bone remodeling by slowing both osteoclasts and osteoblasts, and resulting in 
osteomalacia and adynamic bone disease (Yokel and Golub, 1996: Ch 7, 134-137).   
2.4.2.6 Cancer 
In 1977 a case-control study was done in Quebec, Canada to determine if chronic 
aluminum exposure via inhalation was the cause for an increase in the number of bladder 
cancers found in aluminum production plants.  The study looked at a 10 year period and 
488 cases of which 96 were identified as aluminum production plant employees.  The 
study found that the risk of cancer increased with an increase in estimated exposure to tar 
and PAHs.  The International Agency for Research on Cancer (IARC) made the decision 
that not enough evidence was available to support a theory that aluminum increases the 
risk of bladder cancer.  They felt that cancer risk in the aluminum production industry is 
probably due to known carcinogens already in the plants (Toxicological Profile for 




 Currently, macrophages are studied in vitro in almost all fields of biology.  They 
are found in various tissues, but they all arise in bone marrow then circulate in blood 
where they eventually migrate to specific sites.  They can be obtained from blood, lungs, 
spleen, liver, and the peritoneal cavity (Jakoby and Pastan, 1976: 494-507).  Alveolar 
macrophages (AM) are found in the alveolar sacs deep with in the lungs where they are 
the first line of immunological defense from inhaled particles and serve as a good model 
to understand how inhaled particles can adversely affect health (Kleinman et al., 2003).  
Many studies have used macrophages and their responses to characterize potential toxins.  
Yang, et al., (2000) found that diesel exhaust particles suppress macrophage function.  
Also, Ortega et al. (1992) performed an experiment that illustrated AM decline in 
phagocytosis ability after exposure to cigarette smoke and Furukana et al. (2002) 
characterized the effects of exposure of AM to photocopier toner.  These examples, along 
with many others, have used AM to characterized toxicity of particles that are larger that 
the nanoparticle size range.  Renwick et al. (2001) and (2004) explored the differences in 
toxicity of carbon black and titanium oxide at the nano and macro sizes ranges, showing 
increased toxicity of nanoparticles compared to macro sized particles.  Guang, et al., 
(2005) characterized the cytotoxicity of carbon nanomaterials such as single–walled 
nanotubes, multi-walled nanotubes and fullerene on AM.   
 
2.5.1   Macrophage Role In Immunity 
These immune cells are responsible for regulating inflammation in the healing 
process.  They respond to chemotactic factors produced by inflammatory tissue by the 
releasing molecules that regulate the activity of connective tissue.  They also produce 
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angiogenesis factors that stimulate new blood vessel growth.  In studies where the 
number of macrophages was reduced, wounds healed poorly (Paul, 1989, Ch 5:100). 
These cells are the first line of defense in an infection and rapidly move into 
position at infected sites.  They release mediators that stimulate an acute phase response 
and they activate T lymphocytes (Paul, 1989, Ch 5:100).  T cells will, in turn, activate 
macrophages to attack and destroy many types of infectious agents (Paul, 1989, Ch 1:10-
14). 
  
2.5.2     Phagocytosis 
 Phagocytosis is the process that cells go through to take in large quantities of 
materials that cannot be transported across cell membranes.  One of the main functions of 
macrophages in the immune system is to phagocytose foreign particles.  Alveolar 
macrophages protect the lungs by phagocytosing viable and nonviable particles in the 
alveolar spaces deep within the lungs.  Epidemiological studies indicate correlations 
between moderate particle concentrations in the air and acute effects such as mortality in 
heart, lung disease, and chronic lung morbidity (Lundborg et al., 2001). 
 Particles that are not phagocytosed can cause an increase in infection and lung 
damage (Lundborg et al., 2001).  Because of this, it is important to identify particles that 
are taken in by AM that decrease phagocytosis ability.  Lundborg et al in 2001 showed 
that fine (macro) and ultrafine (nano) carbon particles exposed to AM at a concentration 
of 0.2 micrograms/ 106 AMs, similar to urban areas, resulted in high particle 
concentrations outside the cells and a decrease in AM phagocytosis . Renwick et al in 
2000 looked at carbon black and titanium oxide in the fine and ultrafine sizes ranges.  
Neither of the compounds was directly toxic to the cells, but a significant reduction in the 
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ability of macrophages to phagocytose other particles was seen.  Ultrafine particles 
impaired phagocytosis at lower doses, compared to their macro sized counterparts.  
Guang in 2005, observed that not only do nanoparticles decrease phagocytosis more that 
macro sized particles, but some particles made of the same material will affect 
phagocytosis in AM differently, due to different surface characteristics.  Single walled 
carbon nanotubes were shown to impair phagocytosis more that other carbon 
nanoparticles such as multi-walled nanotubes and fullerene (Guang et al., 2005) 
 Renwick’s research on titanium and carbon black found that when particles 
occupied six percent of the AM volume, clearance of other particles was hindered.  When 
particles occupied sixty percent of the AM volume, clearance of other particles was 
stopped.  They also inferred that ultrafine particle toxicity is more likely to induce 
inflammatory responses.  Fine titanium oxide (250 micrometers), at a nine percent 
loading in AM, caused a 2-fold increase in detention time of foreign particles, where 
ultrafine titanium oxide (20 nanometers) at a 2.5 percent loading in AM caused an 8 fold 
increase in detention time of foreign particles.  This significant difference suggests that 
the mass or volume of a load in an AM is not the determining factor in toxicity, but 
instead the surface area of the particles is (Renwick, et al., 2000). 
 In these phagocytosis studies, Renwick, Lundborg, and Guang dosed 
macrophages with specific particles at nano and micrometer sizes and observed 
phagocytosis ability by adding small latex beads.  They observed how well their 
macrophages phagaocytosed these beads after exposure.  In this research, the same type 




2.5.3    Nitric Oxide (NO) and Cytokines Production 
 The ability of these cells to induce an innate immune response after exposure has 
been measured with cytokine assays (Driscoll, et al., 1990).  Cytokine, along with nitric 
oxide levels, have been used to characterize asthma, chronic obstructive pulmonary 
disease (COPD), bronchiectasis, and acute respiratory distress syndrome (ARDS) 
(Chung, 2001, Kobayashi et al., 2005).   
Kobayashi explained that ARDS, which has 50-70% mortality, is linked to 
elevated levels of NO2, NO3, and cytokines like Interleukin 6 (IL-6), and Interleukin 8 
(IL-8).  These elevated conditions could be important in acute lung injury.  Nitric oxide 
synthase has been shown to be elevated in asthma, bronchiectasis, and other lung 
abnormalities.  Kobayashi also points out that alveolar macrophages are the main source 
of NO and cytokines in ARDS patients and that a long term exposure may be toxic or 
“cytostatic” to those macrophages and other pulmonary cells in close proximity.  These 
elevated levels result in inflammation, and, sustained inflammation was linked to 
mortality (Kobayashi, et al., 2005).  NO has many applications in cell physiology.  
Depending on the target, it can be a neurotoxin, a vasodilator, a neurotransmitter, or it 
may regulate the binding of oxygen to hemoglobin.  It is also linked to cell survival by 
blocking proteins involved in apoptosis, and to cell death by increasing peroxynitrate 
species that block cell respiration (Bossy-Wetzel, et al., 2003).  NO has a pathogenic role 
in diseases in the central nervous system, including ischemia, brain stroke, epilepsy, and 
Parkinson’s disease (Bashkatova, et al., 1998). AMs also produce NO to be used for 
antimicrobial defense (Jorens, et al., 1995), and to regulating cytotoxicity (Paul, 1989, Ch 
28: 772).  Increase of NO production has been seen in rat brain tissue after exposure to 
aluminum and this is significant since high aluminum levels in body tissues have been 
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linked to Alzheimer’s disease (Campbell, et al., 2000).  High aluminum exposure levels 
leading to increase NO levels, have also been linked to suppression of testosterone in 
mice (Guo, et al., 2004).  Bossy-Wetzel et al. (2003) also noticed that elevated NO 
concentrations were necessary in brown adipose tissue to stimulate increased 
mitochondrial efficiency in animals that are hibernating.  This process, known as 
mitochondrial biogenesis, occurs when NO concentrations are slightly elevated, but not 
high enough for NO to out compete oxygen during mitochondrial respiration (Bossy-
Wetzel et al., 2003).   
Chung observed that COPD, which is a chronic obstruction of expiratory flow 
that is seen in chronic bronchitis and emphysema, also has links to increased cytokine 
production.  Macrophages in general are the key source to what Chung calls 
Proinflammatory cytokines.  These include Interlukine-1 (IL-1) IL-6, tumor necrosis 
factor-alpha (TNF-alpha) and colony stimulating factors (CSFs).  IL-1, TNF and IL-6 are 
more specifically called endogenous pyrons that act to increase leukocytosis, release of 
neutrophiles from bone marrow, increase production of other cytokines, increase 
production of adhesive molecules, intercellular adhesion molecules and vascular adhesion 
molecules, and an increase of fibronectin and collagen (Chung, 2001).  These cytokines 
are essential in describing an immune response.  Inflammation during the immune 
response to an exposure is a critical area that needs to be characterized. 
 
2.6  Cell Viability and MTT 
Tetrazolium salt, 3-(4,5-dimethylthiazol-2-y)-2,5-diphenyl tetrazolium bromide 
(MTT), is used  to evaluate cell viability. This assay is colorimetric and evaluates how 
well mitochondrial dehydrogenase of viable cells can reduce MTT to a blue formazan 
 30 
product (Carmichael et al., 1985).  The amount of blue product is measured via a 
spectrophotometer and is used to determine mitochondrial function and viability of a cell.   
2.6.1 Cell Metabolism 
Adenosine triphosphate (ATP) is the primary energy molecule of all cells.  In 
eukaryotes ATP is produced through respiration in mitochondria. The three stages of 
cellular respiration are seen in Figure 2-3.  Nutrients such as sugar, fats and some amino 
acids are used to produce ATP and acetyl groups (two carbon molecules).  These acetyl 
groups then enter the mytosol of the mitochondria and are enzymatically oxidized by the 
citric acid cycle to carbon dioxide and two types of electron carrier molecules, 
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2).  
These electron carriers enter a third stage on the inner membrane of the mitochondria.  
They release an electron down a chain of molecules called the respiratory chain to an 
oxygen molecule that serves as the final electron acceptor and is reduced to form water. 
This allows hydrogen ions (H+) from NADH and FADH2 to be pumped into the 
intermembrane space.  These H+ ions produce a concentration gradient between the 
intermembrane space and the matrix of the mitochondria. The H+ ions will then flow 
back into the matrix through an integral protein in the inner membrane called ATP 
Synthase.  This flow produces the energy needed to convert ADP into ATP (Lehninger, 
Nelson, and Cox, 1993: 446-447). 
                  
Figure 2-4 - Catabolism of proteins, fats and carbohydrates in eukaryotic cells   
(Lehninger, Nelson, and Cox, 1993: 446-447). 
 
2.6.2 Mechanism of MTT Assay 
 MTT is reduced to a blue color if normal metabolic function is maintained by a 
cell.  In order to form this blue color, MTT requires an enzyme located in the respiratory 
chain called succinate-dehydrogenase.  If NADH is available, and in normal metabolic 
conditions it will be, then MTT will be reduced by succinate-dehydrogenase and the blue 
foraman product will appear.   The amount of blue color produced is proportional to the 
number and viability of cells and is an indirect measure of cytotoxicity, mitochondrial 






2.6.3  MTT Assay Use 
In 1985, mitochondria were first being used as a tool to assess chemo-sensitivity 
of cells via MMT assays. Charmicheal et al in 1985 looked at tumor cell mitochondria to 
see if they had the ability to reduce MMT to its blue color.  This assay has been used by 
the Air Force Research Lab (AFRL) to describe the cellular toxicity of hydrazine in 
primary rat hepatocytes (Hussain et al., 2002).  Hydrazine (HzN) is a propellant used by 
the USAF in rocket fuel.  This research is of interest because it was done on a fuel 
component and accepted and performed at AFRL.  The MTT assay was used by Guang to 
assess the toxicity of single-wall, multi-wall nanotubes and fullerene on alveolar 
macrophages (Guang et al., 2005),  and by Renwick to understand the viability of 
alveolar macrophages exposed to carbon black and titanium dioxide nanoparticles and 
micro sized particles (Renwick et al., 2000).    These papers illustrate that the MTT assay 
has been accepted to characterize cell viability of alveolar macrophage cells exposed to 
various nanoparticles.  
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III. Methodology    
3.1 Introduction 
The goal of this research was to characterize the effects of different aluminum 
nanoparticles on rat alveolar macrophages at different concentrations.  This 
characterization was carried out by in vitro methods that used MTT to determine the 
viability of these cells after exposure and a series of functional assays to determine other 
effects on the cells such as immune response, ability to phagocytose particles, and 
morphological changes 
Every experiment contained two preliminary steps, cell culture preparation, and 
exposure of cells to aluminum nanoparticles.  These steps are explained in detail, prior to 
the method explanation of each separate experiment: MTT 24 hr end point, MTT 48, 96, 
122 hour end point, Phagocytosis Index determination, Nitric Oxide production, Cytokine 
production (TNF-a, MIP-2), and morphological changes via Scanning Electron 
Microscopy (SEM).  This methodology will describe assumptions, the lab equipment and 
nanoparticles, and details of the methods for each of the eight experiments used to gather 
data. 
3.2 Assumptions 
Several key assumptions were made at the beginning of the laboratory experiments. 
(1) Characterization properties of Al nanoparticles were expected to change after 
dry powder particles were suspended in deionized water and media.   
(2) Cells dosed at the same Al concentration had an equal level of exposure 
through out the experiment and the exposure method used was satisfactory. 
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(3) Despite the lack of evidence as to the effects of aluminum nanoparticles on 
human health, aluminum nanoparticles were treated as possibly toxic to 
respiratory cells. 
(4) Nanoparticle concentrations were selected from preliminary MTT assay 
results and used in the functional assay experiments.  These concentrations 
were not based on particle deposition data. 
(5) In Vitro results only give insight to in vivo exposure results   
 
3.3 Cell Line 
The NR8383 line was obtained from the American Type Culture Collection 
(ATCC).  The cells were established from normal rat alveolar macrophages obtained by 
lung lavage and isolated on August 3, 1983.  ATCC product description indicates these 
cells exhibit characteristics of macrophages, and they are homogenous and highly 
responsive alveolar macrophages which can be used in vitro to study macrophage related 
activity. 
 
3.4 Cell Culture 
The cells were maintained in Ham’s nutrient mixture F-12 media (Kaighn’s 
modified) and supplemented with 20% fetal bovine serum (FBS), received from 
American Type Culture Collection (ATCC, Manassas, USA). 1% penicillin and 
streptomycin, purchased from Sigma Chemical Company (St. Louis, MO), was added to 
the media mixture. For morphological studies and assays the cells were seeded in 6 or 24-
wells plates and on slides at concentrations ranging between 2.5x105 to 1x106 cells per 
ml.  The cells were incubated in a humidified incubator at 35°C and 5% CO2 atmosphere 
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on a substrate of rat tail collagen. They were cultured to desired cell density prior to 
dosing.  Details on cell culture for each assay are given in future sections. 
       3.4.1  Trypsin 
       Throughout the process of maintaining adequate conditions for cell growth and 
harvesting cells for assays, the cells were removed from the collagen matrix with trypsin 
(Appendix A). 
        3.4.2  Collagen Substrate 
Alveolar macrophages require substrate attachment while growing and developing in 
vitro.  A substrate was created with the use of rat tail collagen and 1% phosphate buffered 
saline (PBS).  One ml of collagen stock solution (25mg/ml) was mixed with 250 ml PBS.  
Depending on the container, a small amount of collagen/PBS solution was added to the 
wells, flasks, and slides.  1 ml per well for six-well plates and two-well slides, 0.5 mL per 
well in 24-well plates, and 5mL in each flask.  Once the collagen was added, the 
containers were placed under UV light for two to four hours.  Then the solutions were 
removed and the containers sat under UV an additional 2-3 hours to allow drying and to 
prevent microbial contamination.  The containers were then wrapped in plastic and 
refrigerated. 
       3.4.3  Cell Count 
In order to measure and compare results from many of these assays, the number of 
cells/ml of media had to be known.  This was determined by using 10 µl of cells in media 
at an unknown, usually a very high, concentration and adding this volume to a 
hemocytometer.  This slide contains numerous grids that are used to help count cells.  
The cells located in the grids on each corner of the slide are counted, and the average 
number of cells in each grid is determined to be the number of cells per 10 µl and, by 
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multiplying that number by 10,000, the number of cells per mL is determined.  The total 
umber of cells in a sample can be determined by multiplying the cells/mL by the number 
of mL in the sample.  The concentration can be adjusted down by diluting the sample, 
using the following equation Cinitial x Vinitial  =  Cdesired x Vdesired. 
3.5 Spectromax 190 
The Spectromax 190 spectrophotometer was used in the data analysis during the 
MTT assays, Nitric oxide assays, and cytokine assays.  The spectrophotometer measured 
emitted light at certain wavelengths for each assay.  The SOFTmax Pro software was 
used to gather and present the data electronically. 
3.6 Nanoparticles 
The test materials, Al2O3-NPs (aluminum oxide nanoparticles 30 nm, 40 nm in 
diameter) and Al-NPs (aluminum nanoparticles 50 nm, 80 nm, 120 nm in diameter and a 
1-2 nm thick oxide coat). were supplied by Dr Karl Martin at Nanotechnologies Inc., 
Austin, TX.  Aluminum nanoparticles, in dry powder form, were suspended in de-ionized 
water to make stock solutions (10mg/ml).  Prior to each use, stock solutions were 
sonicated for 20 seconds to reduce agglomeration of particles. Agglomeration was 
characterized with the Olympus IX71 inverted fluorescent microscope with CytoViva as 
a light source (Appendix G).  Dilutions were made in cell culture media from stock 
solutions and mixed by inverting the container 5 times and vortexing for 5 seconds. The 
pH values ranged between 7.1-7.8, and were verified with each dose range for each 
particle size.  The different concentrations of nanoparticle suspensions were added to 
macrophages cultured in 6 and 24 well cultured plates or chambered cultured slides. 
Details for each assay on aluminum concentrations (dose) are given in future sections.  
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The Tables, 3-1 and 3-2, categorizes nanoparticles by source, size, assay use, and dosing 
range. 
Table 3-1  Nanoparticles Used 
Chemical Size (diameter) Source  Assay Use 
Al2O3 30 nm Nanotechnologies Inc. MTT, NO, TNF-alpha, MIP-2, P.I. 
Al2O3 40 nm Nanotechnologies Inc MTT, NO, TNF-alpha, MIP-2, P.I. 
Al 50 nm Nanotechnologies Inc MTT, NO, TNF-alpha, MIP-2, P.I. 
Al 80 nm Nanotechnologies Inc MTT, NO, TNF-alpha, MIP-2, P.I. 
Al 120 nm Nanotechnologies Inc MTT, NO, TNF-alpha, MIP-2, P.I. 
Ag 25 nm Nanotechnologies Inc MTT positive control 
 
Table 3-2 
Nanoparticle Dosing (0, 25,100, 250 µg/mL media)(FBS Fetal Bovine Serum) 
Particle  0 µg/mL 25µg/mL 100 µg/mL 250 µg/mL 
Al2O3 
30nm 
5 mL 20 % 
FBS 
5 mL of 20 % FBS + 
.0125mL  Al2O3 30nm 
5 mL of 20 % FBS +  
.05 mL  Al2O3 30nm 
4.875 mL of 20 % FBS 
+.125 mL  Al2O3 30nm
Al2O3 
40nm 
5 mL 20 % 
FBS 
5 mL of 20 % FBS + 
.0125mL  Al2O3 40nm 
5 mL of 20 % FBS +  
.05 mL  Al2O3 40nm 
4.875 mL of 20 % FBS 
+.125 mL  Al2O3 40nm
Al     
50nm 
5 mL 20 % 
FBS 
5 mL of 20 % FBS + 
.0125mL  Al 50nm 
5 mL of 20 % FBS + 
 .05 mL  Al 50nm 
4.875 mL of 20 % FBS 
+.125 mL  Al 50nm 
Al     
80nm 
5 mL 20 % 
FBS 
5 mL of 20 % FBS + 
.0125mL  Al 80nm 
5 mL of 20 % FBS +  
.05 mL  Al 80nm 
4.875 mL of 20 % FBS 
+.125 mL  Al 80nm 
Al   
120nm 
5 mL 20 % 
FBS 
5 mL of 20 % FBS + 
.0125mL  Al 120nm 
5 mL of 20 % FBS + 
.05 mL  Al 120nm 
4.875 mL of 20 % FBS 
+.125 mL  Al 120nm 
 
3.7 MTT Assay 
The MTT assay was used to establish alveolar macrophage viability before and 
after exposure to Al nanoparticles.  MTT was assessed by seeding AM on collagen 
coated 24 well plates at 5 x 105 AM/ml in 20% FBS media for 48 hours prior to desired 
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assay time.  24 hours prior to assay time the stock solution of nanoparticles were 
sonicated for 20 seconds, and suspend in 20% FBS media to attain a desired nanoparticle 
media concentration.  Media was removed from each well used during the seeding 
process and replaced with nanoparticle/media solutions and incubated at 37° C .  For a 24 
hr end point the MTT assay was completed the next day, for end points longer than 24 
hours the MTT assay was completed later, and the media/nanoparticle solutions were 
replaced with pure 20% FBS media at 24 hrs.  Assay was performed 48, 96 or 144 hours 
after initial exposure to the particles.  At the desired endpoint, 100 µl of MTT stock was 
added directly to each well.  Plates were incubated at 37° C for 30 minutes at which time 
a  purple color will developed.  The solution was re-suspended and transferred into tubes 
and centrifuged for 2 minutes at 2,000 x g.  The supernatant was discarded, 0.5 ml of 
70% isopropanol was added to each pellet and it was vortex well to obtain homogeneous 
staining.  200 µl of the sample was transferred into wells of a 96 well plate and read on a 
Spectromax 190 spectrophotometer at wavelengths from 570 nm to 630 nm.  The percent 
reduction of MTT was compared to the 0 control (cells not exposed to nanoparticles) 
which represented 100% MTT reduction. 
 
 Each experiment consisted of collecting data for each nanoparticle size, at each 
separate concentration, in triplicate.  Each experiment was then replicated a minimum of 
three times.  Table 3-3 explains the number samples taken and the number of experiments 

















0 control Ag 25nm 
control 
25 µg/ml 
Ag 25nm  
control 
75 µg /ml











24 hr S/E = 3 
E = 3 
TDP = 9 
S/E = 2 
E = 3 
TDP = 6 
S/E = 2 
E = 3 
TDP = 6 
S/E = 3 
E = 3** 
TDP = 45
S/E = 3 
E = 3** 
TDP = 45 
S/E = 3 
E = 3* 
TDP = 27 
S/E = 3 
E = 3* 
TDP = 27
S/E = 3 
E = 3* 
TDP = 27
48 hr S/E = 3 
E = 3 
TDP = 9 
S/E = 1 
E = 3 
TDP =3 
S/E = 1 
E = 3 
TDP = 3 
S/E = 3 
E = 3* 
TDP = 27
S/E = 3 
E = 3* 










96 hr S/E = 3 
E = 3 
TDP = 9 
S/E = 1 
E = 3 
TDP = 3 
S/E = 1 
E = 3 
TDP = 3 
S/E = 3 
E = 3* 
TDP = 27
S/E = 3 
E = 3* 












S/E = 3 
E = 3 
TDP = 9 
S/E = 1 
E = 3 
TDP = 3 
S/E = 1 
E = 3 
TDP = 3 
S/E = 3 
E = 3* 
TDP = 27
S/E = 3 
E = 3* 










E = Number of experiments; S/E = Number of samples taken in each experiment;  
* Cells were dosed at 3 different concentrations of Al (25,100 and 250 µg /ml);                       
** Cells were dosed at 5 different concentrations of Al (25, 50, 100, 250 and 500 µg /ml);  
TDP = Total Data Points used 
 
3.8 Phagocytosis Assay   
 
 This in vitro assay was used to determine the effects of aluminum nanomaterials on the 
phagocytic function of alveolar macrophages.  Cells were seeded on chambered 
microscopic slides at 250,000 cells/ml media for 2 to 4 hours.  The media was then 
replaced with a nanoparticle/media mixture at 25 µg/ml for all Al nanoparticle sizes (30, 
40, 50, 80, 120 nm) and 5 µg/ml for Al 50, 80, and 120 nm.  After 24 hours exposure, the 
media was replaced with a 2 µm latex bead solution for 6 hours at a 10 to 1 ratio (10 
beads per cell).  After 6 hours the cells were washed twice with warm media and placed 
on the Olympus IX71 inverted fluorescent microscope with CytoViva as a light source.  
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The cells in each field of view were counted along with the number of beads in each cell.  
100 cells were counted on each slide and at least 3 slides were counted for each 
nanoparticle at each concentration.  A phagocytosis index (P.I.) was determined by 
multiplying the average number of beads taken in by positive cells by the percent of 
macrophages that were positive.  Table 3-4 explains the number of experiments that were 
completed and number of cells counted.  A draft for the standard operating procedure for 
the assay is found in Appendix C. 
 




0 control  
no Al 
Al 30 nm Al 40 nm Al 50 nm Al 80 nm Al 120 nm 
25 N/A CC/E = 100 
E = 3 
TCC = 300 
CC/E = 100 
E = 3 
TCC = 300 
CC/E = 100 
E = 3 
TCC = 300 
CC/E = 100 
E = 3 
TCC = 300 
CC/E = 100 
E = 3 
TCC = 300 
5 N/A N/A N/A CC/E = 100 
E = 4 
TCC = 400 
CC/E = 100 
E = 4 
TCC = 400 
CC/E = 100 
E = 4 
TCC = 400 
0 CC/E  = 100 
E = 3 
TCC = 300 
N/A N/A N/A N/A N/A 
Total  300 300 300 700 700 700 
     Total 3,000 cells 
 
CC/E = Cells counted per experiment; E = Number of experiments; TCC = Total 
cells counted 
 
3.9 Nitric Oxide Assay 
 
 The nitric oxide assay characterized the effects of Al nanoparticles on an 
inflammatory response.  AM were seeded on collagen-coated 6 well plates with 5 x 105 
AM/ml in 20% FBS media for 48 hours.  At 24 hours prior to supernatant collection the 
stock solution of nanoparticles were sonicate for 20 seconds, and suspended in 20% FBS 
media to obtain a desired nanoparticle media concentrations.  The media was replaced 
with the nanoparticle/media solutions.  The wells were incubated for 24 hours and at least 
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one well was dosed in each experiment with Lipopolysacaride (LPS) as a positive 
control.  In each experiment an extra well was set up so a post treatment cell count could 
be accomplished by washing cells off their collagen substrate and counting them 
microscopically on a hemacytometer.  Media and cells from remaining wells were 
collected and placed into tubes and sonicated for 5 seconds to break open cells.  Cells 
were centrifuged at 12,000 g for 8 minutes and supernatants were collected to measure 
nitric oxide as directed by the manufacturer (Promega).   A detailed explanation of the 
procedure can be found in Appendix D. 
 
 




0 control LPS 
control 
Al 30 nm Al 40 nm Al 50 nm Al 80 nm Al 120 nm 
0 µg/ml S/E = 2 
E = 3 
N/A N/A N/A N/A N/A N/A 
25 µg/ml N/A N/A S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
100 µg/ml N/A N/A S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
250 µg/ml N/A N/A S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
S/E = 2 
E = 2 
10 nmoles N/A S/E = 3 
E = 2 
N/A N/A N/A N/A N/A 
100 nmoles N/A S/E = 2 
E = 1 
N/A N/A N/A N/A N/A 
 
3.10 Cytokine  Assay 
 
The MIP-2 and TNF-α assays were used to characterize effects of Al 
nanoparticles on an inflammatory response.  AM were seeded on collagen-coated 6-well 
plates with 5 x 105 AM/ml in 20% FBS media for 48 hours.  At 24 hours prior to 
supernatant collection the stock solution of nanoparticles were sonicate for 20 seconds, 
and suspended in 20% FBS media to obtain a desired nanoparticle media concentrations.  
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The media was replaced with the nanoparticle/media solutions.  The wells were incubated 
for 24 hours and at least one well was dosed in each experiment with Lipopolysacharide 
(LPS) as a positive control.  In each experiment an extra well was set up so a post 
treatment cell count could be accomplished by washing cells off their collagen substrate 
and counting them microscopically on a hemacytometer.  Supernatant media from 
remaining wells were collected and placed into tubes and frozen at -20 degree Celsius for 
future use.  Cells were centrifuged at 13,000 g for 5 minutes and dilutions were made and 
the cytokine assays were performed as directed by the manufacturer (Biosource).  Table 
3-5 explains the number samples taken and the number of experiments completed.  A 
detailed explanation of both procedures can be found in Appendix E and F. 
 
















0 µg/ml S/E = 3 
E = 4 
N/A N/A N/A N/A N/A 
25 µg/ml N/A S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 
100 µg/ml N/A S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 
S/E = 3 
E = 4 


















3.11   Scanning Electron Micrograph (SEM) 
 
      SEM was used to determine surface morphology changes associated with the 
exposure of alveolar macrophages to Al nanoparticles.  Protocol detail are shown in 
Appendix K   
 
3.12  Statistical Analysis 
   
       All the experiments were done in triplicate and the results were presented as mean ± 
standard deviation. The experimental data was analyzed by ANOVA using Sigma Stat. 
and statistical significance was accepted at a level of p < 0.05. 
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IV.   Data Description and Analysis 
4.1 Introduction 
 
This Chapter presents the data gathered from the methodologies described in  
Chapter 3.  The chapter includes, in this order; 24 hour exposure MTT data of AM to 
Al2O3-NPs ; 48, 96, 144 hour exposure MTT data of AM to Al2O3-NPs; 24 hour exposure 
MTT data of AM to Al-NP; phagocytosis data after 24 hour exposure to Al2O3-NP and 
Al-NP; Immune response of AM via the production of Nitric Oxide, TNF-alpha, and 
MIP-2 after 24 hour exposure to Al2O3-NP and Al-NP; and various images of the cells 
using light microscopy, CytoViva, ESEM, and SEM. 
 
4.2 Alveolar Macrophage Viability Data 
 
The MTT assay measured the viability of the cells.  The colorimetric test evaluates 
viable cell mitochondrial dehydrogenase reduction of MTT to a blue formazan product 
(Carmichael et al., 1985).  Blue formazan, measured via a spectrophotometer, was used to 
determine mitochondrial function and cell viability.  Percent reduction of MTT by cells 
exposed to Al nanoparticles was compared to cells that were not exposed to Al 
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Figure 4-1:  Al2O3-NP Effect on Macrophage Viability  
Percent MTT reduced by Alveolar Macrophages after 24 h of exposure to aluminum 
oxide nanoparticles.  (* asterisk indicates doses that are significantly different than the 
zero control, p value <.05) 
 
Figure 4-1 shows combined results from three separate experiments  in which 
alveolar macrophages were exposed to aluminum oxide nanoparticle for 24 hours at 
doses ranging from 0 to 500 µg aluminum /ml media.  These data confirms that 
aluminum oxide particles do not have a large impact on the viability of these cells even at 
concentrations as high as 500 µg/ml for exposures up to 24 hours. Aluminum oxide 40 
nm at doses between 250 and 500 µg/ml were the only data points that indicate a 
statistical significant difference between the cells not exposed to aluminum particles (0 
mg/ml or control) with a p value < .05. (* asterisk indicates doses that are significantly 
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Figure 4-2: Al2O3-NP Delayed Effects on Macrophage Viability 
 Percent MTT reduced by Alveolar Macrophages after A) 48 h, B) 96 h, and C) 144 h of 
exposure to aluminum oxide nanoparticles.  (* asterisk indicates doses that are 
significantly different than the zero control, p value <.05) 
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The amount of delayed toxicity of these aluminum oxide particles is shown in 
Figure 4-2.  MTT reductions after 48 hrs, in both Al2O3 30 and 40 nm, were significant at 
a dose of 250 µg/ml, decreasing the amount of MTT reduction to approximately 50%.  
Al2O3 40 nm at 100 µg/ml was also significant with a decrease to 60%.  MTT reduction 
after 96 h in both Al2O3 30 and 40 nm were significant at a dose of 250 µg/ml decreasing 
reduction to approximately 52% for 40 nm and 42% for 30 nm.  Al2O3 40nm at 100 
µg/ml was also significantly reduced to approximately 60%.  MTT reduction after 144 h 
in both Al2O3 (30 and 40 nm) were significant at 250 µg/ml with a decrease to 
approximately 35% for both.  Al2O3 30 nm and 40 nm at 100 µg/ml were also significant 
with a decrease to 43% and 45% respectively.  The Al2O3 doses for both 30 and 40 nm 
























Figure 4-3: Al-NP Effect on Macrophage Viability  
Percent MTT reduced by Alveolar Macrophages after 24 h of exposure to aluminum 
nanoparticles.  (* asterisk indicates doses that are significantly different than the zero 
control, p value <.05) 
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Figure 4-3 displays percent of MTT reduction after 24 hours of exposure to 
aluminum nanoparticles (50, 80, 120 nm).   These results indicate that aluminum 
nanoparticles have a more drastic effect on cell viability.  Al 50 and 120 nm created a 
significant reduction in MTT production at 100 and 250 µg/ml, reducing MTT to 54 and 
40% respectively for Al 50 nm, and 61 and 39% respectively for Al 120 nm.  Al 80 nm 
created a significant reduction of MTT at all three dosing points.  At 25 µg/ml MTT was 
reduced to 79%, at 100 µg/ml to 63%, and at 250 µg/ml to 49%.  (* asterisk indicates 
doses that are significantly different than the zero control, p value< .05)  
 
4.3 Alveolar Macrophage Phagocytosis Data 
 
Phagocytic functions of these alveolar macrophages were measured by the uptake of 
2 µm latex beads, observed via the use of an Olympus IX71 inverted fluorescent 






          
25 µg/ml 25 µg/ml 5 µg/ml 5 µg/ml 5 µg/ml 2 µm beads 
No Al 
Al 120nm Al 80nmAl 50nmAl2O3  30nm 
Al2O3  40nm
No Al 
Al 120nm Al 50nm Al 80nm
Al 50nmNo Al Al2O3  40nmAl2O3  30nm Al 80nm Al 120nm 
 
 
Figure 4-4: Alveolar Macrophage Images  
Various images taken during phagocytosis assays with the Olympus IX71 inverted 
fluorescent microscope and CytoViva. Cells were exposed to Al2O3-NP and Al-NPs at 5 
or 25 µg/ml for 24 h. 2 µm fluorescent latex beads were given to the cells after exposure.  
The beads appear as bright globular areas in the cells and were dosed at a 10:1 ratio (10 
beads for every cell) for 6 h. Macrophages and beads phagocytosed by macrophages were 
counted to obtain a Phagocytosis Index (P.I). P.I. = (% macrophages that take in beads) X 
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Figure 4-5: Al2O3-NP and Al-NP Effect on Phagocytosis Ability.  A) Phagocytosis 
Index of Alveolar Macrophages exposed to various Al nanoparticles at 25 mg/ml for 24 
hours B) Phagocytosis Index of Alveolar Macrophages exposed to various Al 
nanoparticles at 5 mg/ml for 24 hours (* asterisk indicates doses that are significantly 







The phagocytosis index utilized in these experiments was developed by Paine et. 
al. in 2004.  Figure 4-5 shows combined results from separate experiments where 
alveolar macrophages were exposed to Al2O3-NP and Al-NP for 24 hours at a dose of 0, 
5 or 25 µg aluminum /ml media.  Al2O3-NP 30 and 40 nm showed a slight, but not 
significant, decrease in phagocytosis ability (p value > .05) when compared to cells not 
dosed with nanoparticles (0 controls).  Al 50, 80, and 120 nm all showed a significant 
reduction in phagocytosis when compared to the control (p value < .05).  Cells exposed to 
5 µg/ml of Al 50, 80, and 120 nm again had a slightly reduced phagocytosis index, but 
only Al 50 nm was significant (p value < .05). (* asterisk indicates doses that are 
significantly different than the zero control, p value < .05)  
 
 
4.4 Alveolar Macrophage Immune Response Data 
 
There was no significant production of Nitric Oxide or Cytokines (TNF-alpha, MIP-
2) after exposure to Al-NPs.  In fact, there was statistically no difference in the amount 
produced at each particle size or dosing concentration up to 100 µg/ml, compared to 
control cells.  The lipopolysaccahride (LPS) positive control illustrates that these cells 
were physiologically able to produce these products, but the lack of production after 
exposure to these nanoparticles suggests that the nanoparticles did not stimulate an 
immune response.  This lack of an immune response suggests that inflammatory damage 
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Figure 4-6: Nitric Oxide Produced by Alveolar Macrophages 24 h post Exposure to Al 
Nanoparticles.  Lipopolysacharride (LPS) was used as a positive control.  NO levels were 
determined via a Greiss reagent assay kit and performed as directed by the manufacturer 
(Promega). (* asterisk indicates doses that are significantly different than the zero control, p 



















































































































Figure 4-7: Cytokine Produced by Alveolar Macrophages 24 h Post Exposure to Al 
Nanoparticles.  A) MIP-2 produces pg/ml,  B) TNF-alpha produced pg/ml.  
Lipopolysacharride (LPS) was used as a positive control.  Cytokine analysis was 
completed with an ELISA Kit and performed as directed by the manufacturer 
(Biosource). (* asterisk indicates doses that are significantly different than the zero 
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*
Figure 4-8:  TNF-alpha Production.  Alveolar Macrophages dosed with Al 
nanoparticles for 24 h then with Lipopolysacharride (LPS) for 24 h.  TNF-alpha analysis 
was completed with an ELISA Kit and performed as directed by the manufacturer 
(Biosource). (* asterisk indicates doses that are significantly different than the LPS 
Control, p value < .05)  
 
To evaluate if the particles are inhibiting the production of TNF-alpha, an 
additional experiment was completed with cells dosed with Al nanoparticle for 24 hrs, 
then dosed with the positive control agent, LPS, for 24 hrs.  As seen in Figure 4-8, the 
cells still produced TNF-alpha.  This indicates there was no particle interference with 
ability of the cells to produce this product and that these particles simply didn’t stimulate 
an in vitro immune response that produced TNF-alpha.  Additional experiments to 





4.5 Alveolar Macrophage Imaging  
 
Three different imaging techniques were used in this research.  The first was basic 
light microscopy with an Olympus CK2-001T microscope.  Selected images from this 
microscope can be seen in Appendix G.  This was useful in comparing viable cell 
numbers with MTT data in early experiments.  The second method used was again light 
microscopy with an Olympus IX71 inverted fluorescent microscope with Cytoviva as a 
light source.  This technique, detailed in Chapter 3, was useful in determining 
phagocytosis information, nanoparticle uptake, and possibly nanoparticle characterization 
for future research.  Selected images are found in Figure 4-4.  The third technique was 
Scanning Electron Microscopy (SEM).  Selected images are found in Appendix G.  It was 
hoped to identify nanoparticle on the outside of the cell, and compare that with TEM 
images of particles inside the cell, but due to limited available time with Transmission 
Electron Microscopy (TEM) and further protocol adjustments with SEM this was not 
possible.  The protocol used for SEM found in Chapter 3 is a good start for future 
research in this area.  
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This chapter summarizes the final results of this research, suggests additional 
research to better understand effects of nanoparticles on cells, discusses methodology 
improvements, and discusses DoD’s interests concerning health and nanotechnology. 
This research compared the in vitro response of Rat Alveolar Macrophages to 
various sizes of aluminum nanoparticles to determine toxic effects on cell viability and 
functionality.  Cell viability was assessed via the MTT assay, measuring the metabolic 
activity of mitochondria.  The functionality of these cells was assessed with both 
phagocytosis and cytokine production assays.  In addition to these assays, advances in 
imaging these cells were made during this research. 
 
5.2 Conclusions 
5.2.1 Viability and Respiration 
Al2O3-NPs did not display significant toxicity after 24 hours of exposure to the 
AM cells, but after extended times, 96 and 144 hours, at higher doses, 100 and 250 
µg/ml, a statistically significant reduction was seen in the metabolic activity of the cells.  
Al-NPs were slightly more toxic than Al2O3-NPs after 24 hours at higher doses, 100 and 
250 µg/ml.  
The slight decrease of MTT reduction in cells exposed to 40 nm Al2O3 and the 
unaffected reduction of MTT by cells exposed to high doses of 30 nm Al2O3 indicate 
only slight to no effect on AM cell viability after 24 hours of exposure.  A delayed effect 
on viability was shown to occur between 96 and 144 hours, at high exposure levels for. 
Al2O3-NP.  Delayed toxicity for Al-NP was not investigated since significant toxicity was 
seen after 24 h.   
The percent MTT reduction in the Al-NP and Al2O3-NP did not seem to be size or 
surface area dependent, see surface area figure for each nanoparticle size in appendix L.  
The major difference in viability seemed to be the result of the chemical composition of 
the nanoparticles or possibly other characteristics not investigated.  The same seemed to 
be true for the phagocytosis ability of these macrophages after exposure to Al2O3-NP and 
Al-NP for 24 h.  The AL-NPs seem to restrict the phagocytic function of the cell more 
than Al2O3-NP, and again, there were no statistical differences between different Al-NP 
sizes. 
 
Figure 5-1  LD50 Dose Estimates and Low Exposure Phagocytosis Reduction 
X-axis shows LD50 dose estimates for these aluminum nanoparticles on AM.      
Y-axis shows a significant reduction in the % phagacytosis ability of AMs 
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Phagocytosis assays were done to examine the possibility that these particles will 
have an effect on the function of phagocytosis AM.  As shown in Figure 5-1 the 
estimated LD50 dose for each nanoparticle was relatively high.  50 nm Al-NPs were the 
most toxic with an estimated LD50 dose of 130µg/ml and Al Oxide 30 and 40 nm were 
both well above 500 µg/ml. Since AM cell viability was not significantly affected at 
lower exposure levels, these additional assays were run to measure the cell’s functional 
abilities.  When cells were dosed at lower, non toxic levels (25 µg/ml), Al-NPs all caused 
a statistically significant reduction in phagocytosis.  Even at 5 µg/ml, 50 nm Al-NP 
caused a 48% reduction in phagocytosis that was statistically significant compared to the 
control. The inability of the cells to function properly could contribute to the onset of 
infection since these impaired macrophages will not be able to quickly clear bacteria that 
make it to the alveoli (Lundborg, et al., 2001).  In addition, synergistic effects might 
occur between materials and particles that were in the air with Al-NPs.  Previously non-
toxic materials or particles, usually consumed by macrophages, could contribute to 




5.2.3 Immune Response 
 
The immune response of alveolar macrophages to aluminum nanoparticles was 
measured by determining the degree of nitric oxide and cytokine (TNF-alpha, MIP-2) 
production by the cells.  Increased immune response would indicate potential for 
inflammatory damage to tissue.   Lipopolysaccharide was used as a positive control and 
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demonstrated these cells do produce these inflammatory products at expected levels.  
Exposure to each size of aluminum nanoparticles produced no statistical difference 
between the amount of cytokine or nitric oxide produced from cells exposed compared to 




Various techniques for imaging cells and their interactions with nanoparticles were 
explored.  These included basic light microscopy, fluorescent light microscopy with 
CytoViva, and a procedure for Scanning Electron Microscopy (SEM), see Appendix G 
for various images.  Each of these techniques was useful in directing the focus of this 
research.  Basic light microscopy was critical in completing cell counts, observing cell 
confluency, and determining initial nanoparticle doses that had an effect on cell viability 
prior to and in conjuction with the MTT assays.  The fluorescent light microscope proved 
to be very useful in determining the phagocytosis ability of the AM cells and observing 
the extent to which these nanoparticles agglomerated.  The SEM imaging, not as 
successful, was used to gain more information on cell morphology and particle location 
on the cell membrane.  Image quality and instrument availability was problematic, but a 
few images did show likely nanoparticle agglomerations on the outside of cells.  
Additional technique modifications with SEM along with TEM imaging will be needed in 
order to determine nanoparticle locations in respect to the AM cells and overall changes 






5.3 Recommended Additional Research 
 
Nanotechnology interactions with environmental and human health still need to be 
addressed. This research has uncovered additional concerns with respect to in vitro 
studies that are beyond the scope of this thesis. This section discusses recommendations 
for additional studies, ranging from particle uptake and characterization to regulation and 
control of these nanoparticles during mass production or release.  
 
5.3.1 Particle Uptake 
One question that is a concern and leads to numerous others is the issue of uptake of 
nanoparticles in exposed cells.  Are the particles agglomerated on the cell membrane 
surface or are they crossing the membrane?  If the later, how are they getting in: 
phagocytosis, endocytosis, physical trauma, etc.; then where are they going: cytoskeletol 
elements, nucleus, ribosomes, etc.; and finally, are they interfering with physiological 
processes such as: protein synthesis, DNA replication, cell locomotion, etc?  First, better 
techniques to determine concentration of particles in the cells after they have been 
exposed at various exposure concentrations and times are needed. Second, precise 
particle locations inside the cells need to be evaluated to determine any functional 
changes, beyond death, that these nanoparticles might have on the cell. 
This is a difficult task that could possibly be accomplished with common 
technologies.  SEM and TEM have been used to determine where particles are in relation 
to the cell and its organelles.  Techniques that use atomic absorption and inductive 
coupled plasma are now being explored to determine mass concentration of metallic 
nanoparticles in cells.  Fluorescent studies with nano-sized latex beads could also be used 
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to model uptake.  Appendix I illustrates two proposed methods for Nanoparticle uptake 
that utilize atomic absorption and fluorescent latex beads. 
 
5.3.2 Mechanism of Cell Death 
 
An additional question is the cause of death after exposure.  Fink et al. in 2005 
explains the differences between apoptosis, a type of self programmed cell dismantling 
that avoids inflammatory responses, and necrosis, a passive accidental death that can lead 
to uncontrolled inflammatory response.  The method of death influences tissue damage 
due to inflammation.  Cell responses like mitochondrial membrane potential, annexin 
binding, DNA fragmentation, caspase activation, and cytochrome C release can be 
measured in order to determine what type of cell death is predominant. 
5.3.3    Characterization and Exposure 
 
A limitation of nanoparticle toxicology has been the lack of physical 
characterization of the particles that the cells are exposed to. Recently Oberdorster et al. 
(2005) addressed this issue and determined certain key characteristics; size distribution, 
shape, composition, particle physicochemical structure, agglomeration state, method of 
production, storage of material, and concentration, are essential characteristics that need 
to be evaluated.  Slight change in any of these factors may cause  nanoparticles to be 
more or less toxic.  It is still widely believed by many that, due to small particle size, an 
increased surface area interaction is one of the most important factors.  If a 
manufacturing process creates particles of the same size, but a slightly different surface 
chemistry, this could be crucial to toxicity.  Results from this research showed Al-NPs to 
be more toxic than Al2O3-NPs.  
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Another big factor is the method of exposure of cells to particles.  Do the methods 
and procedures used mimic in vivo exposure, and, if so, have any of the nanoparticle 
characteristics changed in the process?  For example, particles dispersed in water may 
have different properties than particles dispersed in PBS or media.  Particles in high dose 
concentrations may have different properties than particles at low concentrations.  
Particles agitated prior to exposure may have different properties than particles not 
agitated. This can become an important issue in how often particles are characterized, 
how reliable are the results, and how much time and money should be spent on this? 
A synergistic effect may occur between materials and particles that are in the air 
with Al-NP.  Since nanoparticles may impair alveolar macrophage function, as was seen 
by Al-NPs, effects of other materials commonly aerosolized with nanoparticles during 
production, handling, and use should be investigated.  Materials or particles, usually 
consumed by macrophages and previously thought harmless, may contribute to fibrosis, 
infection, or other diseases in the lungs. 
5.3.4 Modeling 
 
Once enough data is collected, an attempt to model cellular effects should be made.  
This may be useful in finding trends associated with the physically characteristics of the 
particles (size, shape, chemistry, etc.), the type of cells effected, or various other 
biological interactions.  These trends may be useful in hypothesizing the toxic effects of 
future nanoparticles even before they are used.  First, in vitro data from numerous cell 
lines including skin, lung, kidney, liver, and digestive tissues should be collected.  
Second, data should include both viability and functional effects of the nanoparticles on 
the cells.  Third, the nanoparticles used should be highly characterized according to all 
elements explained by Oberdorster et al. (2005).  Finally, the hope is that good modeling 
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should lead to further studies and offer information on in vivo exposure levels.  These in 
vivo exposure levels could eventually lead to identifying exposure limitations that should 
be made in a work environment. 
 
5.3.5 Future DoD Applications and Concerns 
 
A big financial push has been made toward nanotechnology.  As illustrated in the 
2005 report on Defense Nanotechnology Research and Development Programs, over 230 
million dollars (annually) has been allotted toward R&D for nanotechnology in DoD.  
The fact is these materials, if not already, will soon be in our work place.  A better 
evaluation of exposure limitations and environmental measurement techniques need to be 
addressed.  A collaborative effort between DoD, private industry and NIOSH on this 
matter should be investigated.  DoD as well as numerous other companies have an 
interest in production of nanomaterials other that titanium oxide and carbon black, but the 
current NIOSH strategic plan seems to have a limited focus on these two particle types, 
see Appendix H (NIOSH strategic plan, 2005).   
A proactive effort should also be made by DoD on how these materials are to be 
regulated (see Appendix J).  In a 2003 Case study of Single Walled Carbon Nanotubes, 
completed by the Woodrow Wilson International Center for Scholars, numerous loop 
holes where found in how well the Toxic Substance Control Act (TSCA) monitored the 
production of these new materials (Nanotechnology and Regulation Case study, 2003).   
Research should be conducted to determine the best nanoparticle use policy that protects 





Appendix A: Trypsinizing Cells 
 
In order to maintain adequate conditions for cell growth and harvesting the cells had 
to be removed from their collagen matrix with trypsin. 
1. Trypsin was brought to room temperature to avoid stress to the cells 
 
2. Growth media was suctioned from each flask 
 
3. 1 ml of .25% trypsin was injected into each flask and allowed to coat the entire 
surface of the flask and incubated for 1-2 minutes 
 
 
4. 5 ml media was added to each flask and aspirated with a pipette over the entire 
surface of the flask many times to allow for the cells to be washed from their 
collagen matrix 
 
5. A desired volume of media containing cells was placed into another flask, or 
counted to determine a concentration of cells, and seeded to a 6 or 24 well plate 
for an assay, or to a slide for microscopic examination. 
 
6. All plates, flasks, and slides were allowed to incubate for 2-3 hours to allow for 
cells to reattach to the collagen substrate. 
 
7.   The final step of the process was to suction out all media that contained trypsin  























Appendix B: MTT Assay 
 
The MTT assay was used to establish alveolar macrophage viability before and after 
exposure to Al nanoparticles. 
1.  Macrophages were seeded on collagen coated 24 well plates at 5 x 105 AM/mL in  
     20% FBS Media 48 hours prior to desired assay. 
 
2.  24 hours prior to assay, stock solution of nanoparticles were sonicated for 20  
     seconds, and suspend in 20% FBS to attain desired nanoparticle media concentration 
 
3.  Media was replaced with nanoparticle/media solutions and incubated at 37 degrees  
     Celsius 
 
 a.  For a 24 hr end point, the MTT assay, as explained below, was completed the   
                 next day at the same time 
 b. For the 48, 96, 144 hr end point the MTT assay was completed as explained  
                 below, but the media/nanoparticle solution was suctioned out and replaced  
with pure 20% FBS media after 24 hrs, and each assay was performed 48, 96 
or 144 hr after initial exposure to the particles 
 
4. In the 24 well plates, 100 µl of MTT stock was added directly into the media in each     
    well.  
 
5. The plate was incubated at 37° C until color developed (usually 30 minutes). 
 
6. The solution was re-suspended and transferred into 1.5 ml tubes. 
 
7. The tubes were centrifuge for 2 minutes at 2,000 x g. 
 
8. The supernatant was removed and 0.5 ml of 70% isopropanol was added to each   
     tube with pellet. 
 
10. The pellet was vortexed well to obtain homogeneous staining. 
 
11. 200 µl of the samples were transferred into wells of a 96 well plate. 
 
12. Plates were read on the Spectomax 190 at 570 nm to 630 nm.  
 
13. Percent reduction is compared to the 0  or blank control.  







Appendix C: Phagocytosis Assay  
AFRL SOP Draft 
 
AL/OET                                                                                        SOP NO:  (Draft) 
Standard Operating Procedure (Draft) 
Author:  1st Lt. Andrew Wagner 
Date:  26 September 2005                                                                                   
______________________________________________________________________ 
PHAGOCYTOSIS ASSAY  
 
       
 
PURPOSE/PRINCIPLE:  This standard operating procedure describes the in vitro method of 
determining what effects different nanomaterials will have on the phagocytic function of 
alveolar macrophages. 
 
KEY WORDS:  Phagocytosis, alveolar macrophages, nanotoxicity. 
 
 
1.     SAFETY AND OPERATING PRECAUTIONS: 
 
 1.1 Wear appropriate gloves, eye goggles and lab coat when handling hazardous 
materials. 
 
 1.2 Properly dispose of unused/spent toxic materials (nanoparticles). 
 
2.    EQUIPMENT/MATERIALS: 
 
 2.1 F12K medium supplemented with 20 % fetal bovine serum (FBS), 1 % penicillin 
and streptomycin. 
 
 2.2 2 chambered microscope slides, and clean glass microscope cover slips 
 
2.3 2 µm latex beads (Sigma Aldrich Product #L3030,  
  (www.sigmaaldrich.com/catalog/search/SearchResultsPage/Expand) 
 
 2.4 Nanomaterials of interest  
 
 2.5 Olympus IX71 Inverted Fluorescent Microscope with CytoViva 150 attachment     
and 12 bit QICAM from IMAGINE (Lab 160) 
 
3.   SPECIMEN/SAMPLE:  250,000 Alveolar Macrophages in 1ml media 
 




5.   PROCEDURE: 
 
5. 1  Seed macrophages on collagen coated 2 chambered slides at a low density approximately 
2.5 x  105 AM/ml in media containing 20% FBS for 2-4 hours prior to step 5.2 
 
5.2    24 hour (or other desired time period) prior to microscopic evaluation suspend desired 
nanomaterials in cultured media with 20% FBS to attain desired material concentration in 
cultured media. 
 
5.3 Expose cells to the different concentrations of nanomaterials in cultured media.  After a 
desired time period of exposure cell concentrations are determined by washing selected 
wells with Media.  The cells are washed off their collagen substrate and counted via the 
cell counting method explained previously by Dr. N. DelRaso (30 Jan 1995). 
 
5.4         Once cell concentrations are determined a bead concentration ratio of 10 beads to 1 cell    
(2 µm Beads: number of cells) in 20% FBS media is used to replace the       
nanomaterial/media solution in the slide chambers that were not counted 
 
5.5         Cells expose to beads in cultured media are then incubated for 6 h at 37oC. 
 
5.6  After 6 h of incubation, cells are washed twice with media at room temperature.  The   
              chambers on the slides are removed as described in the manufacturer’s instruction and a  
              cover slip is placed on top of the sample.  The edges of the cover slip are adhered to the  
              slide and are sealed with fingernail polish to avoid movement. 
 
5.7        Cells should first be counted with the CytoViva light on while fluorescence light is off. 
 
5.8        Beads inside cells can then be counted with fluorescence and CytoViva on.  Open and       
              close the fluorescent shutter as needed and focus with the fine adjustment to view and   
              count all beads in a cell 
 
5.9         Start the cell count in the middle of the slide and count every cell in a field of view and               
              the number of beads within each cell.  Once all cells are counted move the field of      
              view up the slide vertically and once again count each cell.  If the edge of the slide  
             appears before 100 cells are counted move the field of view horizontally and then   
             proceed down  vertically counting.    
 
6.    DATA ANALYSIS/RECORDS: 
  
6.1       A Phagocytosis Index (PI) is determined after 100 cells are counted.   
  (PI = percent macrophages that took beads in multiplied by the average number of  
   beads taken in by a positive macrophage) 
 
6.2     The average number of beads taken in by a positive macrophage and the average number 
           of positive macrophages are additional data points that can be used. 
 
7.   QUALITY CONTROL: 
 
7.1 Repeat Experiment at least three times for a total cell count of 300 cells for each 




8.    LIMITATIONS OF PROCEDURE:  N/A 
 
9.    PROCEDURE NOTES:  N/A 
 
10.   REFERENCES:   
 
Renwick, L.C., K. Donaldson, and A. Clouter (2001). Impairment of Alveolar 
macrophage Phagocytosis by Ultrafine Particles, Toxicology and Applied  
Pharmacology 172, 119–127 
 
Paine, R., Morris, S.B., Hong, J., Wilcoxen, S.E., Phare, S.M., Moore, B.B., Coffey, 
M.J., Toews, G.B., 2001, Impaired functional activity of alveolar macrophages from GM-
CSF-deficient mice.  American Journal of Physiology Lung Cell Molecular Physiology 
281: 1210-18 
 





































Appendix D:Nitric Oxide Assay 
This nitric oxide assay was used to characterize effects of Al nanoparticles on an 
Alveolar Macrophages inflammatory response.   
 
1.  Macrophages were seeded on collagen coated 6 well plates with 5 x 105 AM/mL in    
     20% FBS media for 48 hours prior to desired assay time 
 
2.  24 hours prior to assay time the stock solution of nanoparticles were sonicate for 20     
     seconds, and suspended in 20% FBS to attain desired nanoparticle media  
     concentrations. 
 
3.  Media was replaced with nanoparticle/media solutions.  The wells were incubated for    
     24 hours 
 
4.  After 24 hour exposure to the nanoparticles cell concentrations in the slide wells were  
     determined by washing selected wells with Media.  The cells were washed off their  
     collagen substrate and counted via the cell counting method explained in 3.5 
 
5.  Cells were scraped off the bottom of each well. 
 
6.  Cells and supernatant were sonicated for 5 seconds 
 
7.  Cells and supernatant were centrifuged for 8 minutes at 1200g 
 
8.  Nitric Oxide assay performed as directed by manufacturer (Promega) 
 
9.  A nitrite standard curve was created: 
 
A.   A 100µM nitrite solution was prepared by diluting the 0.1M Nitrite Standard 
1:1,000 in the matrix or buffer used for the experimental samples. 
 
B.   Three columns (24 wells) in a 96-well plate were designated for the Nitrite 
Standard reference curve (Figure A-1). 50µl of the appropriate matrix or buffer 
was dispensed into the wells in rows B.H. 
 
C.   100µl of the 100µM nitrite solution was added to the remaining 3 wells in 
row A. 
 
D.   Serial two fold dilutions (50µl/well) in triplicate, were performed down the 
plate to generate the Nitrite Standard reference curve (100, 50, 25, 12.5, 6.25, 
3.13 and 1.56µM), discarding 50µl from the 1.56µM set of wells.  No nitrite 







10.  Nitrite Measurement (Griess Reaction): 
 
A.   Sulfanilamide Solution and NED Solution was allowed to equilibrate to room 
temperature (15-30 minutes). 
 
B.   50µl of each experimental sample was added to wells in duplicate or  
triplicate. 
 
C.   50µl of the Sulfanilamide Solution was added to all experimental samples and 
wells containing the dilution series for the Nitrite Standard reference curve. 
 
D.   Samples were incubate 5-10 minutes at room temperature, protected from  
light. 
 
E.   50µl of the NED Solution was added to all wells. 
 
F.   Samples were incubate 5-10 minutes at room temperature, protected from  
light.  
 
G. Absorbance was measure on the Spectromax 190 within 30 minutes  with a  
Filter between 520-550nm.  
 
11.  Determination of Nitrite Concentrations in Experimental Samples: 
 
A.   A Nitrite Standard reference curve was generated by plotting the average 
absorbance value of each concentration of the Nitrite Standard as a function of 
"Y" with nitrite concentration as a function of "X". 
 
B.   The average absorbance value of each experimental sample was determined. 
Sample concentrations were determined by comparison to the Nitrite Standard 
reference curve. 
 
          
                  
Appendix D Figure A:  Nitrate Standard reference curve used to calculate unknown 



































Appendix E: TNF-alpha Assay 
 
This TNF-alpha assay was used to characterize effects of Al nanoparticles on 
Alveolar Macrophages inflammatory response 
1.  Macrophages were seeded on collagen coated 6 well plates with 5 x 105 AM/ml in    
     20% FBS media for 48 hours  
 
2.  24 hours prior to supernatant collection the stock solution of nanoparticles were                                          
     sonicate for 20 seconds, and suspended in 20% FBS to attain desired nanoparticle      
     media concentrations. 
 
3.  Media was replaced with nanoparticle/media solutions.  The wells were incubated for   
     24 hours 
 
4.  After 24 hour exposure to the nanoparticles cell concentrations in the 6 well plates    
     were determined by.  The cells were washed off their collagen substrate and counted    
     via the cell counting method explained in 3.5 
 
5.  Supernatant media from each of the wells not counted were collected and placed into    
     1.5 ml tubes and frozen at -20 degree Celsius for future use. 
 
6.  Supernant liquids were thawed at room temperature and centrifuged at 1200 g for 5  
     minutes. 
 
7.  1:4 dilutions of the supernants were used (determined by previous experiments) as      
      samples and the TNF-alpha assays were performed as directed by the manufacturer    
     (Biosource) with slight modifications 
 
9.  A TNF-alpha standard curve was created:  (see Figure A-2) 
 
a. The standard provided was reconstituted to 5000 pg/ml with Standard Diluent  
    Buffer. 
b. 0.100 ml of the reconstituted standard was added to a tube containing 
     0.400 ml Standard Diluent Buffer 
c. 0.250 ml of Standard Diluent Buffer was added to each of 6 tubes 
    labeled 500, 250, 125, 62.5, 31.2 and 15.6 pg/ml Rat TNF-alpha. 
d. Serial dilutions of the standard were made. 
 
10.  The desired number of 8 well strips was inserted into the frame provided 
 
11. 50 µL of the Incubation Buffer was added to all wells.  
 
12. 100 µL of the Standard Diluent Buffer was added to the zero wells.  
 
13. 100 µL of standards or controls was added to the appropriate wells, and 100 µL of     
      sample to each well.  
 
14. 50 µL of biotinylated anti-TNF-α (Biotin Conjugate) Solution was pipetted into each     
      well.  
 
15. Plates were covered and incubate for 1 hour and 30 minutes at room temperature. 
 
16. Solutions were discarded and washed four times with wash solution. 
 
17. 100 µL of Streptavidin-HRP working solution were added to each well. 
 
18. Plates were covered and incubate for 45 minutes at room temperature. 
 
19. Solutions were discarded and washed four times with wash solution. 
 
20. 100 µL of Stabilized Chromogen was added to each well.  
 
21. The wells were incubated for about 15 minutes at room temperature and in the dark. 
 
22. 100 µL of Stop Solution was added to each well. (The solution in the wells should     
       change from blue to yellow). 
 
23. The absorbance of each well was read at 450 nm.  
 
24. The absorbance data was compared to the standard TNF-alpha curve and  
      concentrations were determined 
 
         
Appendix E Figure A:  TNF-alpha Standard Reference Curve used to calculate 
unknown sample concentrations  
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Appendix F: MIP-2 Assay 
This MIP-2 assay was used to characterize effects of Al nanoparticles on Alveolar 
Macrophages inflammatory response 
 
1.  Macrophages were seeded on collagen coated 6 well plates with 5 x 105 AM/ml in    
     20% FBS media for 48 hours  
 
2.  24 hours prior to supernatant collection the stock solution of nanoparticles were   
     sonicate for 20 seconds, and suspended in 20% FBS to attain desired nanoparticle    
     media concentrations. 
 
3.  Media was suctioned replaced with nanoparticle/media solutions.  The wells were   
     incubated for 24 hours 
 
4.  After 24 hour exposure to the nanoparticles cell concentrations in the 6 well plates    
     were determined.  The cells were washed off their collagen substrate and counted via    
     the cell counting method explained in 3.5 
 
5.  Supernat media from each of the wells not counted were collected and placed into    
     1.5 ml tubes and frozen at -20 degree Celsius for future use. 
 
6.  Supernant liquids were thawed at room temperature and centrifuged at 1200 g for 5  
     minutes. 
 
7.  1-10 dilutions of the supernants were used (determined by previous experiments) as      
      samples and the MIP-2 assays were performed as directed by the manufacturer    
     (Biosource) with slight modifications 
 
9.  A MIP-2 Standard Curve was created: (see Figure A-3) 
 
a. The standard provided was reconstituted to 2000 pg/ml with Standard Diluent  
    Buffer. 
b. 0.160 ml of the reconstituted standard was added to a tube containing 
     0.340 ml Standard Diluent Buffer 
c. 0.150 ml of Standard Diluent Buffer was added to 6 tubes 
    labeled 320, 160, 80, 40, 20 and 10 pg/ml Rat MIP-2. 
d. Serial dilutions of the standard were made. 
 
10.  The desired number of 8 well strips was inserted into the frame provided 
 
11. 50 µL of the Standard Diluent Buffer was added to the zero wells.  
 
12. 50 µL of standards or controls were added to the appropriate wells, and 50 µL of     
      sample to each well.  
 
13. 50 µL of biotinylated anti-MIP-2 (Biotin Conjugate) Solution was pipetted into each     
      well.  
 
14. Plates were covered and incubate for 2 hours at 37 degree Celsius. 
 
16. Solutions were discarded and washed four times with wash solution. 
 
17. 100 µL of Streptavidin-HRP working solution was added to each well. 
 
18. Plates were covered and incubate for 1 hour at room temperature. 
 
19. Solutions were discarded and washed four times with wash solution. 
 
20. 100 µL of Stabilized Chromogen was added to each well.  
 
21. The wells were incubated for about 15 minutes at room temperature and in the dark. 
 
22. 100 µL of Stop Solution was added to each well. (The solution in the wells should 
change from blue to yellow). 
 
23. The absorbance of each well was read at 450 nm.  
 
24. The absorbance data was compared to the standard MIP-2 curve and  
      concentrations were determined. 
 
           
 
 
Appendix F Figure A: MIP-2 Standard Reference Curve used to calculate unknown 
sample concentrations  
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Appendix F Figure B: Biosource Immunoassay Kit Catalog #KRC1022/KRC1021, 


























Appendix G:  Selected Images 
 
 a b 
Appendix G Figure A: SEM images of Alveolar Macrophage not exposed to Al-NP 9-
28-2006. a) 3300 x magnification, b) 2700 x magnification 
 
 a b 
Appendix G Figure B:  SEM images of Alveolar Macrophage 24 h post exposure with 
50 nm Al-NP at 25 μg/ml on 9-28-2005.  a) 4300 x magnification, arrows indicate 
extensions of plasma membrane. b) 9500 x magnification, ovals indicate possible 










a b c  
Appendix G Figure C: SEM images of Alveolar Macrophage 24 h post exposure with 
80 nm Al-NP at 25 μg/ml on 9-28-2005.  a) 3500 x magnification, arrows indicate 
possible damage to plasma membrane. b) 6000 x magnification, arrow indicates 
extension of plasma membrane.  c)  Area in yellow square in b, arrows indicate possible 


















    
c d 
Appendix G Figure D:  Light Microscopy Images of Rat Alveolar Macrophages 
(Olympus CK2-001T)  a) No aluminum exposure at 20X magnification, cells have a high 
density and are considered confluent  b) No aluminum exposure at 60X magnification, 
magnification of confluent cells in image a.  c) 40 nm Al Oxide exposure at 250 μg/ml 
for 24 h at 60 X magnification, cell density is noticeably lower than control (images a and 
b), and less resolution on cell membranes, compared to control, indicating possible 
membrane damage d) 40 nm Al Oxide exposure at 500 μg/ml for 24 h at 60 X 
magnification, cell density is noticeably lower than control (images a and b), and less 
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Appendix G Figure E:  Dispersion and Agglomeration of Al2O3-NPs and Al-NPs 
a 1-3 Al2O3 30nm  1) Dispersion from left to right;10mg/ml in de-ionized water (stock 
solution), Media only, 25μg/ml of 20% FBS media, 100μg/ml of 20% FBS media, 




 1-3 Al2O3 40nm  1) Dispersion from left to right;10mg/ml in de-ionized water (stock 
X71 
cope 
 1-3 Al 50nm  1) Dispersion from left to right;10mg/ml in de-ionized water (stock 
X71 
cope 
 1-3 Al 80nm  1) Dispersion from left to right;10mg/ml in de-ionized water (stock 
X71 
cope 
 1-3 Al 120nm  1) Dispersion from left to right;10mg/ml in de-ionized water (stock 
X71 
cope 
inverted fluorescent microscope and Cyto Viva) 25μg/ml of 20% FBS media.  3) 
Agglomeration (60X magnification on Olympus IX71 inverted fluorescent micros
and Cyto Viva) 100 μg/ml of 20% FBS media. 
 
b
solution), Media only, 25μg/ml of 20% FBS media, 100μg/ml of 20% FBS media, 
250μg/ml of 20% FBS media.  2) Agglomeration (60X magnification on Olympus I
inverted fluorescent microscope and Cyto Viva) 25μg/ml of 20% FBS media.  3) 
Agglomeration (60X magnification on Olympus IX71 inverted fluorescent micros
and Cyto Viva) 100 μg/ml of 20% FBS media. 
 
c
solution), Media only, 25μg/ml of 20% FBS media, 100μg/ml of 20% FBS media, 
250μg/ml of 20% FBS media.  2) Agglomeration (60X magnification on Olympus I
inverted fluorescent microscope and Cyto Viva) 25μg/ml of 20% FBS media.  3) 
Agglomeration (60X magnification on Olympus IX71 inverted fluorescent micros
and Cyto Viva) 100 μg/ml of 20% FBS media. 
 
d
solution), Media only, 25μg/ml of 20% FBS media, 100μg/ml of 20% FBS media, 
250μg/ml of 20% FBS media.  2) Agglomeration (60X magnification on Olympus I
inverted fluorescent microscope and Cyto Viva) 25μg/ml of 20% FBS media.  3) 
Agglomeration (60X magnification on Olympus IX71 inverted fluorescent micros
and Cyto Viva) 100 μg/ml of 20% FBS media. 
 
e
solution), Media only, 25μg/ml of 20% FBS media, 100μg/ml of 20% FBS media, 
250μg/ml of 20% FBS media.  2) Agglomeration (60X magnification on Olympus I
inverted fluorescent microscope and Cyto Viva) 25μg/ml of 20% FBS media.  3) 
Agglomeration (60X magnification on Olympus IX71 inverted fluorescent micros
and Cyto Viva) 100 μg/ml of 20% FBS media.  
 
Appendix H NIOSH Strategic Plan  
Figure A: Strategic Plan for NIOSH Nanotechnology Research: Filling the Knowledge 
Gaps Excerpt from Appendix A:  
 
TEN CRITICAL OCCUPATIONAL SAFETY AND HEALTH ISSUES 























Metal Nanoparticles at 
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Cells Maintained In Vitro                       
(alveolar macrophages, karotinocytes 
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collect data at 2 h  intervals for 24 h0 
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Dose cells at various concentration and 
collect data at 6 h intervals for 24 h 
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1.  Wash Cells 
2.  Cell Imaging with Fluorescent Microscope 



































      I.         Identify Nanotechnology uses across USAF 
      A.  Current Documents 
  1.  Defense Nanotechnology Research and Development Programs 
  2.  Etc 
       B.  Request for Information from USAF Nanotechnology Working Groups  
  1.  POC 
  2.  Material / Particle (Characteristics) 
  3.  Use 
  4.  Current number of people exposed  
  5.  Projected number of people exposed once implemented  
  6.  Projected implementation 
  8.  Projected mission impact 
  9.  Current Controls 
10. Etc. 
 
I. Health Effects 
           A.  Literature Review 
       B.  DoD In Vitro Data 
       C.  DoD In Vivo Data  
D.  DoD Epidemiology Data 
E.  Collaborative Data 
F.  Etc. 
 
II. Environmental and Work Place Measurement Method Review  
A.  Literature Review 
B.  Collaboration with Experts 
 1.  NIOSH 
 2.  Private Industry 
 3.  Etc. 
III. Risk Assessment 
A.  Parameters to consider  
 1.  Likelihood of use (Answered: I.) 
2.  Projected number of people exposed once implemented (Answered: I) 
 3.  Known Health Effects (Answered: II) 
 4.  Effectiveness of Control Techniques 
 5.  Impact on Mission (Answered: I.) 
 6.  Etc. 
 
 B.  Formulate a Prioritized list of Nanoparticles/materials  
  1.  Recommend toxicology studies from this list 
2.  Suggest NIOSH consider modifying its Strategic Plan as needed  
3.  AFRL apply for Grants 
 a. Environmental and work place measurement methods 
 b. Toxicity studies   
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Appendix K:  SEM Protocol  
 
1.  Macrophages were seeded on Aclar polymer discs in 24 well plates at 2.5 x 105   
     AM/ml in 20% FBS media for 24 hours 
 
2.  The 20% FBS media was suctioned from each well and the cells were washed twice   
      with PBS by gently filling each well with 2mL for 10 minutes then repeating. 
 
3.   1 mL of fixative solution (2.5% glutaraldehyde in 0.1M  sodium cacodylate pH 7.4)           
      was added to each well and placed in refrigerator at 4 °C for 1 hour. 
 
4.  Fixative was suctioned from each well and washed three times for 15 minutes with 0.1   
     M Na cacodylate buffer, pH 7.4 (0.2M buffer was diluted with distilled deionized    
     water). 
 
5.  Buffer was suctioned and cells were dehydrated in a series of (50, 70, 80, 95, 100,  
     100, 100%) ethanol.  1mL of ethanol was added for 15 minutes then removed for  
      the next step in the series.  The last step in the series was left overnight in a  fresh  
      3 mL of 100% ethanol in a closed dish. 
 
6.  Cells were transferred in the 24 well plates in 100% ethanol to the microscopy lab at  
      the University of Dayton. 
 
7.  The cells were critical point dried and mount to SEM stub. 
 
8.  The cells were coated with gold in sputter coater and image in High Resolution SEM. 
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Al Oxide 40 nm18 Al 120 nm  
28 Al 80 nm 
44 Al 50 nm 
38 Al Oxide 40 nm 
50 Al Oxide 30 nm 
SSA (m2/g) Particle 
 
Appendix L Figure A: Surface Area of Al Nanoparticles.  A) Specific Surface Area 
provided by Nanotechnologies characterization studies on the materials.  B)  Calculated 

































Aitken, R.J., Creely, K.S., Tran, C.L., “Nanoparticles: an Occupational hygiene review”, 
 Prepared by the Institute of Occupational Medicine for the Health and Safety 
 Executive 2004, Research Report 274 (2004). 
 
Arnell Golden Gregory web-site (12/8/2003) “21st Century Nanotechnology Research 
 and Development Act”.  10 October 2005 
 http://www.agg.com/Contents/PublicationDetail.aspx?ID=800&PrintViewEnable 
  
Bashkatova, V.G., Rayevsky, H. S., “Review: Nitric Oxide in Mechnaisms of Brain 
 Damage Induced by Neurotoxic Effect of Glutamate” Russian Academy of 
 Medical Sciences (1998). 
 
Baydar, T., Sahin, G., Aydin A., Isimer, A., Akalin, S., Duru, S., “Al/Cr ratio in plasma 
 and urine of diabetics”, Trace Elements and Electrocytes 13; 50-53 (1997). 
 
Beers, M.H., Berkow, R., The Merck Manual of Diagnosis and Therapy , Merck 
 Research Laboratories, Whitehouse Station, N.J 1999 
 
Biosource Immunoassay Kit Catalog #KRC1022/KRC1021, 2003, Rat MIP-2. 10 January 
 2006 
 http://www.biosource.com/content/catalogContent/tds3/moreinfo/KRC1022.pdf  
 
 




Bossy -Wetzel, E., Lipton, S.S., “Nitric Oxide signaling regulates mitochondria number 
 and function”, Cell Death and differentiation 10: 757-760 (2003). 
 
 91
Cameron, R.S., Ritchie, G.S.P., Robson, A.D., “Relative Toxicities of Inorganic 
 Aluminum Complexes to Barley”, Soil Science Society Americal Journal 50; 
 1231-1236 (1986). 
 
Campbell, A., Kumar, A., La Rosa, F.G., Prasad, H.N., Bondy, S.C.,  “Aluminum 
 Increases Levels of ß-Amyloid and Ubiquitin in Neuroblastoma But Not in 
 Glioma Cells”, Experimental Biology and Medicine 223:397-402 (2000). 
 
Carmichael, J., Degraff, W.G., Gazdar, A.F., Minna, J.D., Mitchell J.B.,  “Evaluation of a 
 tetrazolium-based semi automated colorimetric assay: Assessment of chemo 
 sensitivity testing”, Cancer Res. 47, 936-942 (February 1987). 
 
 
Chung K.F., “Cytokines in chronic obstructive pulmonary disease”,  European 
 Respiratory Journal 18: 50-59 (May 2001). 
 
 
Colvin, V.,  “The potential environmental impacts of engineered nanomaterials”, Nature 
 Biotechnology 21:1166–1170 (October 2003). 
 
DelRaso,N.J., “Microculture Tetrazolium Assay (MTT) In Plated Hepatocyte Cultures”, 
 Standard Operating Procedure number PD-97-015, Air Force Research  
 Laboratory (1996). 
 
Department of Defense Director, “Defense Research and Engineering, 2005, Defense 
 Nanotechnology Research and Development”.  4 January 2006 
 http://www.nano.gov/html/res/DefenseNano2005.pdf  
 
Dingman, S., Grocholl, L.,Rohatgi, K.P., Schultz, B., Ferguson, J.B., “Nanomaterials for 
 Advanced Applications”,Sigma-Aldrich.com ChemFiles 5: 4-10 (2005). 
 
Dreher, K., “Health and Environmental Impact of Nanotechnology: Toxicological 




Driscoll, K.E., Higgins, M.J., Leytart, J.M., Crosby, L.L., ” Differential effects of mineral 
 dusts on the in vitro activation of alveolar macrophage eicosanoid and cytokine 
 release”, Toxicology in Vitro 4: 284-288 (2002). 
 
Elechiguerra, J.L., Burt, J.L., Morones, J.R., Camacho-Bragado, A., Gao, X., Lara, H.H., 
 Yacaman, M.J.,  “Interaction of silver Nan particles with HIV-1”, Journal of 
 Nanobiotechnology 3:6 (June 2005). 
 
EPA, NSF, NIOSH Joint Research Solicitation, 2005, Nanotechnology Research Grants 
 Investigating Environmental and Human Health Effects of Manufactured.  
 10 October 2005 http://www.me.gatech.edu/me/events/other/nano.pdf  
 
Exley, C., “A Biogeochemical Cycle for Aluminum?”, Journal of Inorganic Biochemistry
  97; 1-7 (September 2003). 
 
Fink, S.L., Cookson, B.T.,  “Apoptosis, Pyroptosis, and Necrosis: Mechanistic 
 Description of Dead and Dying Eukaryotic Cells”,  Infection and Immunity: 1907-
 1916 (2005). 
 
 
Furukawa, Y., Aizawa, Y., Okada, M., Watanabe, M., Niitsuya, M., Kotant,M., 
 “Negative Effect of Photocopier Toner on Alveolar Macrophages Determined by 
 In Vitro Magnetometric Evaluation”, Industrial Health 40; 214-221 (2002). 
 
 
Guang, J., Haifang, W., Lei, Y., Xiang, W., Rongjuan, P., Tao, Y., Yuliang, Z., Xinbiao, 
 G., “Cytotoxicity of  Carbon Nanomaterials: Single-Wall Nanotube, Multi-Wall 
 Nanotube and Fullerene”, Environmental Science and Technology 39: 1378-83 
 (2005). 
 
Gumpta, A.K., Gumpta, M.,  “Cytotoxicity suppression and cellular uptake nhancement 
  of surface modified magnetic Nan particles”, Biomaterials 26: 1565- 573 (2005). 
 
Guo, C.H., Lin, C.Y., Yeh, M.S., Hsu, G.S.W.,  “Aluminum induced suppression of 
 testosterone through nitric oxide production in male mice”, Environmental 
 Toxicology and Pharmacology 19; 33-40 (2003). 
 
 93
Guo, C.H., Huang, J.C., Chen, S.T, Hsu, G.S.W., “Serum and testicular testosterone and 
 nitric oxide products in aluminum-treated mice”, Environmental Toxicology and 
 Pharmacology 10; 53-60 (2001). 
 
Gray, Lynn.  Biology Instructor, Tyler Junior College, Tyler TX.  TEM and SEM 
 Protocol Telephone Interview. 9 September 2005 
 
Hoffman, D., “Environmental Law and Nanotechnology.  Power Point Slides presented 
 to National Nanotechnology Infrastrucure Network’s “Nanosafe”: A Workshop 
 on Environmental Health and Safety in Nanotechnology Research”. (2004) 
 7 July 2004: http://www.nnin.org/doc/David%20Hoffman.pdf  
 
Howard, J.,  “Strategic Plan for NIOSH Nanotechnology Research Filling the Knowledge 
 Gaps”.  Nanotechnology Research Program National Institute for Occupational 
 Safety and Health Centers for Disease Control and Prevention (2005). 
 
Hunley, J.D.,  “The History of Solid-Propellant Rocketry: What we do and do not know, 
 American Institute of Aeronautics and Astronautics”, Presented as an Invited 
 Paper at the 35th AIAA, ASME, SAE, ASEE Joint Propulsion Conference and 
 Exhibit (1999). 
 
Hussain, S.M., Frazier, J.M., “Cellular Toxicity of Hydrazine in Primary Rat 
 Hepatocytes”, Toxicological Sciences 69: 424-432 (2002). 
 
Itzhaki, R.F.,  “Possible Factors in the Etiology of Alzheimer’s Disease”, Molecular 
 Neurobiology 9: 1-13 (1994). 
 
Jakoby, W.B., Pastan, I.H.  Cell Culture: Methods in Enzymology Volume LVIII, 
 Academic Press, Inc. San Diego, CA. 1979 
 
Jorens, P.G., Boelaert, J.R., Halloy, V., Zamora, R., Schneider, Y.J., Herman, G.A.,  
 “Human and Rat Macrophages Mediate Fungistatic Activity against Rhizopus 
 94
 Species differently: In Vitro and Ex Vivo Studies”, Infection and Immunity 63
 : 4489-4494 (November1995). 
 
Kleinman, M.T., Sioutas, C., Chang M.C., Boere, A.J.F, Cassee, F.R., “Ambient Fine and 
 coarse particles suppression of alveolar macrophage functions”, Toxicology 
 Letters 137: 151-158 (February 2003). 
 
Kukowska-Latallo, ,J.F., Candido, A.K.,Cao, Z., Nigavekar, S.S., Majoros,J.I., Thomas, 
 T.P., Balogh, L.P.,Khan, K.M., Baker, J.R.,  “Nanoparticle Targeting of 
 Anticancer Drug Improves Therapeutic Response in Animal Model of Human 
 Epithelial Cancer”, Cancer Research 65: 5317-5324 (2005). 
 
Kuennen, T.,  “Small Science Will Bring Big Changes to Roads”, Better Roads, (2004) 
 19 July 2005 www.betterroads.com/articles/jul04a.htm 
 
Kreuter, J.,  “Nanoparticle-based dmg delivery systems”, Journal of Controlled Release 
 16: 169-176 (1991). 
 
Kobayashi, A., Hashimotto, S., Kooguchi, K., Kitamura, Y., Onodera, H., Urata, Y., 
 Ashihara, T.,   “Expression of inducible nitric oxide synthase and inflammatory 
 cytokines in alveolar macrophages of ARDS following sepsis”, Chest 113: 1632-
 1639 (June 1998). 
 
Lehninger, A.L., Nelson, D.L., Cox, M.M., Principles of Biochemistry, Second Edition.  
 Worth Publishers, NewYork, NY 1993 
 
Loney, Dennis,  “Weapons that Tread Lightly”,  The Website of the American Chemical 
 Society (2004).  10 January 2006 
 http://www.chemistry.org/portal/a/c/s/1/feature_ent.html?DOC=enthusiasts%5Ce
 nt_greenexplosives.html  
 
 
Lundborg, M., Urban, J., Lena, L., Per Gerde; Per Cammer, “Human Alveolar 
 Macrophage Function is Impaired by Aggregates of Ultrafine Carbon Particles”,  
  Environmental Research Section A 86: 244-253 (2001). 
 95
 
Miziolek, A., “Nanoenergetics: An Emerging Technology Area of National Importance”, 
   AMPTIAC Quarterly 6: 43-48 (Spring 2002). 
 
Mulhausen, J.R., Domingo, J.,  A Strategy for Assessing and Managing Occupational 
 Exposures. American Industrial Hygiene Association, Fairfax, VA. 1998 
 
“Nanotechnology and Regulation: A Case study using the Toxic Substance Control Act” 
 Woodrow Wilson International Center for Scholars (2003). 
 
Noble, A.D., Summer, M.E., Alva, A.K., “Comparison of Aluminum and 8- 
 Hydroxyquinoline Methods in the Presence of Fluoride for Assaying Phytotoxic 
 Aluminum”, Soil Science Society American Journal 52: 1059-1063 (1988) 
 
Oberdorster, G., Maynard, A., Donaldson K., Castranova, V., Fitzpatrick, J., Carter, J., 
 Karn, B., Kreyling, W., Lai, D., Olin, S., Monteiro-Riviere, N., Warheit, D., 
 Yang, H.,  “Particle and Fibre Toxicology, Review: Principles for characterizing 
 the potential human health effects from exposure to nanomaterials: elements of a 
 screening strategy”, BioMed Central (2005) 
 http://www.particleandfibretoxicology.com/content/pdf/1743-8977-2-8.pdf   
 
Ortega, H.E., Collazos, M.E., Pedrera, M.I., Barriga, C., Rodriguez, A.B.,  “Phagocytosis 
 of latex beads by alveolar macrophages from mice exposed to cigarette smoke”,  
  Comparative Immunology Microbiology and Infectious Diseases 2: 137-142 
 (April 1992). 
 
Paine, R., Morris, S.B., Hong, J., Wilcoxen, S.E., Phare, S.M., Moore, B.B., Coffey, 
 M.J., Toews, G.B., “Impaired functional activity of alveolar macrophages from 
 GM-CSF-deficient mice”, American Journal of Physiology Lung Cell Molecular 
  Physiology 281: 1210-18 (November 2001). 
 
Palaszewski, B.,  “Nanotechnology Investigated for Future Gelled and Metallized Gell 
 Fuels” (2002)  10 October 2005




Palaszewski, B.,  “Propellant Technologies: A Persuasive Wave of Future Propulsion 
 Benefits”, A White Paper, NASA Glenn Research Center, (1997) 24 February  
 2005 http://sbir.grc.nasa.gov/launch/Propellant.htm 
 
 
Paul, W.E., Fundamental Immunology, Second Edition. Raven Press, New York, NY. 
 1989 
 
Pavan, A.M.,Pratt, F.P, Bingham,F.T.,  “Toxicity of Aluminum to Coffee in Ultisols and 
 Oxisols Amended with CaCO3, MgCO3 and CaSO4 2H2O”, Soil Science Society 
 American Journal 46: 1201-1207 (1982) 
 
Pithawalla, Y.B., Sarojini, D.,  “Chemical synthesis of iron aluminide [FeAl] and iron 
 aluminum carbide [Fe3AlC0.5] Nan powders”, Materials Research Bulletin 39: 
  2303-2316 (December 2004). 
 
Renwick, C.L., Brown, D., Clouter, A., Donaldson, K., “Impairment of Alveolar 
 Macrophages Phagocytosis by Ultrafine Particles” Toxicology and Applied 
 Pharmacology 172: 119-127 (2001) 
 
Renwick, C.L., Brown, D.,Clouter, A., Donaldson, K.,  “Increased inflammation and 
 altered macrophage chemotactic responses caused by ultrafine particle types”,  
 Occupational Environmental Medicine 61: 42-447 (May 2004). 
 
Robertson, J.,  “Realistic applications of CNTs”, Materialstoday, Engineering 
 Department Cambridge University 46-52 (2004). 
 
Roco, M.C., “Government Nanotechnology Funding: An International” (2003) Outlook. 
 10 October 2005 http://www.nano.gov/html/res/IntlFundingRoco.htm  
 
Romano, J., “Spheres of Influence: Minuscule balls of nickel may well help power cars 
 and usher in the hydrogen economy”, Nanotechnology 2: (2005) 10 October 2005 
 www.memagazine.org/nanoapr05/index.html   
 
Science Web site “Advanced Search –Science Magazine” 27 January 2006 
 http://www.sciencemag.org/search.dtl   
 
Schrand, A., PhD Student, University of Dayton.  “Basic Protocol for the Preparation of 
 Cells for SEM” handout received 24 May 2005 
 
 97
Shin, R.W., Lee, V.M., Trojanowski, J.Q.,  “Aluminum modifies the properties of 
 Alzheimer’s disease PHF tau proteins in vivo and in vitro”, The Journal of 
 Neuroscience 14: 7221-7233 (1994). 
 
Toxicological Profile for Aluminum (update), Prepared by: Syracuse Research 
 Corporation, Prepaired for: U.S. Department of Health and Human Services, 
 Agency for Toxic Substances and Disease Registry (1999). 
 
 
Tyner, MK., Schiffman, S.R., Giannelis, E.P., “Nanobiohybrids as delivery vehicles for 
 camptothecin”, Journal of Controlled Release 3: 501-514 (2004) 
 
White House Press Release, January 5, 2005, Legal Reform: The High Costs of Lawsuit 
 Abuse, The White House Office of the Press Secretary 
  
Yang, H.M., Antonini, J.M., Barger, M.W., Butterworth, L., Robers, R.J., Ma, K.H.J., 
 Castranova, V., Ma, J.Y.C.,  “Diesel Exhaust Particles Suppress Macrophage 
 Function and slow the pulmonary Clearance of Listeria Monocytogenes in Rats”, 
 Environmental Health Perspectives 109: 515-521 (May 2001). 
 
Yang, L., Watts, D.J.,  “Particles surface characteristics may play an important role in 
 phytotoxicity of aluminum Nan particles”, Toxicology Letters 158: 122-132 
 (August 2005). 
 
Yokel, R.A., Golub, M.S., Research Issues in Aluminum Toxicity. Taylor and Francis, 


















 1st Lt Andrew J. Wagner graduated from Mabank High School in Mabank, Texas.  
He attended Tyler Junior College,  Stephen F. Austin State University and completed his 
undergraduate studies in biology at the University of Texas in Tyler in 1999.  He taught 
High School Science from 1999 to 2001 and then was commissioned through Officer 
Training School in February 2002 where he was recognized as a Distinguished Graduate. 
 His first assignment was at Wright-Patterson AFB where he was the Executive 
Officer for the School of Systems and Logistics at the Air Force Institute of Technology 
(AFIT/LS) and latter became the OIC of the Commandants Action Group at AFIT .   In 
August 2004, he entered AFIT’s Graduate School of Engineering and Management.  
Upon graduation, he will be assigned to Edwards AFB, California. 
REPORT DOCUMENTATION PAGE 
Form Approved 
OMB No. 074-0188 
The public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, 
gathering and maintaining the data needed, and completing and reviewing the collection of information.  Send comments regarding this burden estimate or any other aspect of the collection of 
information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information Operations and Reports (0704-0188), 
1215 Jefferson Davis Highway, Suite 1204, Arlington, VA  22202-4302.  Respondents should be aware that notwithstanding any other provision of law, no person shall be subject to an penalty 
for failing to comply with a collection of information if it does not display a currently valid OMB control number.   
PLEASE DO NOT RETURN YOUR FORM TO THE ABOVE ADDRESS. 
1. REPORT DATE (DD-MM-YYYY) 
23-03-2006 
2. REPORT TYPE  
Master’s Thesis     
3. DATES COVERED (From – To) 
Apr 2005-Feb 2006 
5a.  CONTRACT NUMBER 
5b.  GRANT NUMBER 
 
4.  TITLE AND SUBTITLE 
 
     IN VITRO TOXICITY OF ALUMINUM NANOPARTICLES IN RAT 
ALVEOLAR MACROPHAGES 
   
 
5c.  PROGRAM ELEMENT NUMBER 
5d.  PROJECT NUMBER 
 
5e.  TASK NUMBER 
6.  AUTHOR(S) 
 
Wagner, Andrew, J 1st Lt 
 
5f.  WORK UNIT NUMBER 
7. PERFORMING ORGANIZATION NAMES(S) AND ADDRESS(S) 
     AFIT/ENV 
 2950 Hobson Way 
     WPAFB OH 45433-7765 
8. PERFORMING ORGANIZATION 
    REPORT NUMBER 
 




9.  SPONSORING/MONITORING AGENCY NAME(S) AND ADDRESS(ES) 
 Hussain, Saber, M. Civ AFRL/HEB 
Air Force Research Lab HEPB 
WPAFB, Bldg 837, Area B, 2729 R St 
WPAFB OH 45433-7765 
Tel: 937-904-9512 
11.  SPONSOR/MONITOR’S REPORT 
NUMBER(S) 
12. DISTRIBUTION/AVAILABILITY STATEMENT 
              APPROVED FOR PUBLIC RELEASE; DISTRIBUTION UNLIMITED. 
 
13. SUPPLEMENTARY NOTES  
 
14. ABSTRACT  
 The purpose of this research is to characterize the in vitro cellular effects of rat lung macrophages to exposure to aluminum 
oxide nanoparticles (Al2O3-NP) (30 and 40nm) compared to aluminum nanoparticles (Al-NP) (50, 80, and 120nm). This study 
concentrates on cell viability, mitochondrial function, phagocytosis ability, and cytokine response.  Results indicate no to 
minimal toxicological effects on macrophages exposed as high as 500 μg/ml for 24 hours with Al2O3-NP.  However, there was 
a significant delayed toxicity that occurred at 96 and 144 h post exposure.  Al-NP shows sight to moderate toxicity after 24 h 
exposure at 100 and 250 μg/ml. The phagocytic ability of these cells was significantly hindered by exposure to each size of the 
Al-NP at 25 μg/ml for 24 hours, but not by the Al2O3-NP.  A series of cytokine and nitric oxide assays performed show none 
of these aluminum nanoparticles are inducing an inflammatory response.  
 
 
15. SUBJECT TERMS 
       Nanotechnology, Nanoparticle exposure, Aluminum, Alveolar Macrophage, In Vitro exposure                                                            
16. SECURITY CLASSIFICATION 
OF: 
19a.  NAME OF RESPONSIBLE PERSON 





c. THIS PAGE 
U 
17. LIMITATION OF  
     ABSTRACT 
 
UU 
18. NUMBER  
      OF 
      PAGES 
111 19b.  TELEPHONE NUMBER (Include area code) (937) 255-3636, ext 4721; e-mail: charles.bleckmann@afit.edu 
Standard Form 298 (Rev: 8-98) 
Prescribed by ANSI Std. Z39-18 
 
 
